dawnpowell

634 POSTS 0 COMMENTS

Implantation of JenaValve successful in initial patients enrolled in CE mark...

JenaValve Technology has announced initiation of patient enrolment and implantations associated with the CE mark study of its next-generation JenaValve pericardial transcatheter aortic valve...

Bisexual men have more risk factors for cardiovascular disease

According to a study published in LGBT Health, bisexual men have a higher risk for cardiovascular disease compared with heterosexual men across several modifiable...

Physicians are more willing to tolerate uncertainty about coronary artery disease...

Steven Farmer (Center for Healthcare Innovation and Policy Research, George Washington University, Washington, DC, USA) and others report in JAMA Cardiology that, following the...

Advantage of guided de-escalation of dual antiplatelet therapy seen in younger...

A pre-specified analysis of the TROPICAl-ACS study indicates that de-escalating dual antiplatelet therapy (DAPT), as guided by platelet function testing, after percutaneous coronary intervention...

First patient enrolled in phase II of REFLECT study of TriGuard...

Keystone Heart announced the launch of phase II of the REFLECT trial, which is evaluating the next-generation TriGuard 3 cerebral protection device. According to a...

Ron Waksman

Ron Waksman (MedStar Heart & Vascular Institute, Washington, DC, USA) is the course chairman of Cardiovascular Research Technologies (CRT; 3–6 March, Washington, DC, USA),...

US FDA approve EchoMD AutoEF software for calculating left ventricular ejection...

Bay Labs has received US FDA 510(k) clearance for its its EchoMD AutoEF software product for the fully automated clip selection and calculation of...

Caladrius receives FDA regenerative medicine advanced therapy designation for its CD34+...

Caladrius has revealed that the US FDA has granted regenerative medicine advanced therapy (RMAT) designation to its late-stage CD34+ cell therapy programme for the...

EuroPCR 2018: Study indicates “almost perfect agreement” between CT angiography and...

A new study, SYNTAX III REVOLUTION, has found heart teams using computed tomography (CT) angiography to decide between percutaneous coronary intervention (PCI) and coronary...

EuroPCR 2018: Both immediate and delayed approaches seem to work for...

A new study indicates that a delayed approach in patients with transient ST-segment elevation myocardial infarction (STEMI) is associated with similar safety and efficacy...

Combination of high-sensitive C-reactive protein with logistic EuroSCORE improves risk stratification...

According to Anja Stundl (Department of Medicine II, Heart Center Bonn, University Hospital, Bonn, Germany) and others, high-sensitive C-reactive protein (hs-CRP) can be used...

EuroPCR 2018: Will SPYRAL-ON change my practice?

In this PCR video, David E Kandzari (Department of Interventional Cardiology, Piedmont Heart Institute, Atlanta, USA) speaks to Atul Pathak (National Institute of Health and...

Consider patients’ risk of ischaemic stroke when choosing antiplatelet therapies after...

New data from ADAPT-DES, published in JACC: Cardiovascular Interventions, indicate that higher platelet reactivity units (PRU) is associated with an increased risk of ischaemic...

EuroPCR 2018: Low incidence of cardiovascular mortality with Centera self-expanding valve...

Hermann Reichenspurner (Departments of Cardiovascular Surgery and General and Interventional Cardiology, University Heart Center, Hamburg, Germany) at EuroPCR (22 May—25 May, Paris, France) reported...

Corindus receives Japanese PMDA approval for its CorPath GRX system

Corindus Vascular Robotics has received Pharmaceutical and Medical Device Agency (PMDA) approval for commercialisation of its CorPath GRX system in Japan. A press release...

EuroPCR 2018: No significant difference in bioprosthetic valve dysfunction between surgical...

The NOTION trial (Nordic aortic valve intervention) was the first comparison of surgical and transcatheter aortic valve implantation (TAVI) in patients at lower surgical...

EuroPCR 2018: Real-world data confirm trial outcomes for Sapien 3

Thirty-day data presented at EuroPCR (22 May—25 May, Paris, France) show consistently positive patient outcomes for patients undergoing transcatheter aortic valve implantation (TAVI) with...

Cardiology societies come together to provide key advice for dealing with...

The American College of Cardiology (ACC), Heart Rhythm Society (HRS), North American Society for Cardiovascular Imaging (NASCI), Society for Cardiovascular Angiography and Interventions (SCAI),...

EuroPCR 2018: FFR-guided PCI reduces spontaneous myocardial infarction

Five-year data from FAME (Fractional Flow Reserve vs. Angioplasty for Multivessel Evaluation) 2 show that patients with stable disease who undergo percutaneous coronary intervention...

Looks do matter—patients claim what doctors wear is important

According to a study published in BMJ Open, just over half of patients think what a doctor wears is important and more than a...

Cardiovascular News Issue 49—May 2018 US edition

For our May 2018 edition (Issue 49), we report on the key studies from the 2018 American College of Cardiology Scientific Session – including...

Cardiovascular News Issue 49—May 2018

For our May 2018 edition (Issue 49), we report on the key studies from the 2018 American College of Cardiology Scientific Session - including...

BCS 2018: Novel blood test for myocardial infarction could be used...

Data presented at the British Cardiovascular Society Conference (4–6 June, Manchester, UK) indicate that a novel blood test for diagnosing myocardial infarction could one...

Biomerics acquires FutureMatrix Interventional

Biomerics has bought FutureMatrix Interventional, which specialises in the design and manufacture of interventional catheters for the cardiovascular and urinary markets. A press release...

US FDA classifies HeartWare HVAD power issues as a Class I...

The US FDA has classified Medtronic’s recent voluntary urgent field action related to the HeartWare HVAD system’s unexpected power source switching as a Class...

EuroPCR 2018: New ORBITA analysis finds iFR/FFR values do not predict...

New data from the ORBITA trial indicates percutaneous coronary intervention (PCI) does not significantly reduce exercise time compared with a sham procedure in patients...

ADVERTORIAL: Sentinel Cerebral Protection System provides reassurance to both physicians and...

Compared with first-generation devices, new-generation transcatheter aortic valve implantation (TAVI) devices—along with iterative approaches in technique and imaging—have partially reduced the documented stroke rates...

EuroPCR 2018: Data confirms long-term safety and efficacy of Angiolite drug-eluting...

At EuroPCR (22 May–25 May, Paris, France), the 12-month results of the ANGIOLITE trial were presented for the first time by J Moreu Burgos....

EuroPCR 2018: PiCSO therapy reduces infarct size in acute myocardial infarction...

The clinical results from the OxAMI-PiCSO study—published in EuroIntervention and presented at EuroPCR (22 May–25 May, Paris, France)—provide further evidence for the use of the...

The European Commission authorise use of evolocumab to reduce risk of...

The European Commission (EC) has authorised a new indication in the evolocumab (Repatha, Amgen) label for adults with established atherosclerotic cardiovascular disease—myocardial infarction, stroke...

EuroPCR 2018: Interim nine-month results for Magnitude presented

Amaranth Medical provided an update on its sirolimus-eluting bioresorbable scaffold products during a satellite symposium at EuroPCR (22 May—25 May, Paris, France), including Magnitude...

Positive clinical results from eCOBRA study

CeloNova BioSciences has announced one-year clinical trial results from the eCOBRA post-market study of its Cobra PzF nano-coated stent. The clinical trial results demonstrated...

EuroPCR 2018: One- to two-year landmark analysis shows significantly lower target...

Two-year outcome data from the BIO-RESORT randomised controlled trial, which were presented in a late-breaking clinical trials session by Marlies M Kok (Thoraxcentrum Twente,...

EuroPCR 2018: Strong early vessel healing with Resolute Onyx in one-month...

Investigators unveiled clinical data from the independently run Onyx 1-Month OCT Study, which showed strong early vessel healing in a patient population that contained...

EuroPCR 2018: DIAB8 randomised study to compare Cre8 Evo with everolimus-eluting...

Alvimedica unveiled the details of the Diab8 study—the first diabetic drug-eluting stent randomised trial—during EuroPCR (22–25 May, Paris, France). Diab8 is a 55-centre, 3,040-patient...

ADVERTORIAL: Taking control of LDL-C when statin therapy is not enough

This content is for distribution within the UK only. This content is for distribution within the UK only. Currently, statins are the most common lipid-lowering therapy...

Xience Sierra approved for use in USA

Abbott has announced it has received approval from the US FDA for its Xience Sierra, the newest generation of the company’s gold-standard Xience everolimus-eluting...

EuroPCR 2018: Further evidence for safety and efficacy of Magmaris bioresorbable...

Data presented during EuroPCR (22 May – 25 May, Paris, France) provide further evidence on its continued safety and efficacy, also in a more complex...

EuroPCR 2018: Positive data for renal denervation reignites interest in...

After two studies indicated that renal denervation lowers blood pressure both with and without antihypertensive drugs, Felix Mahfoud (Klinik für Innere Medizin III, Saarland...

EuroPCR 2018: Two studies provide support for HeartFlow Analysis

New data from the PACIFIC study presented at EuroPCR (22 May – 25 May, Paris, France) showed that the HeartFlow Analysis had the highest...

Intravascular Lithotripsy for coronary artery disease launched in Europe

Intravascular Lithotripsy (Shockwave Medical) is now available, on the European market, for the management of calcified coronary artery disease. Additionally, according to a press...

“Excellent valvular function” with NaviGate’s GATE tricuspid valved stent at...

A press release reports that the first patient to receive the GATE tricuspid valved stent (NaviGate) via transjugular access has reached one-year post-procedure with...

Enrolment of US early feasibility study of AccuCinch system for left...

Ancora Heart has announced the expansion of its US feasibility study to evaluate the investigational AccuCinch ventricular repair system designed for the treatment of...

EuroPCR 2018: Boston Scientific outlines its key presentations

Boston Scientific Corporation has revealed its schedule of key presentations—including two late-breaking clinical trials—that will be featured at the 2018 EuroPCR (22–25 May, Paris,...

First patient treated in first-in-man study of ChordArt mitral valve repair...

CoreMedic has announced the start of the first-in-man Chagall study to evaluate the new minimally-invasive valve repair technology ChordArt. A press release reports that...

Use of Resolute Onyx to be explored for the treatment of...

Medtronic has announced the initiation of a clinical study in the US to assess the safety and efficacy of drug-eluting stents for the treatment...

EuroPCR 2018: First-in-human study of Leaflex Performer for aortic stenosis initiated

Pi-Cardia has recently started its first-in-human study with its Leaflex Performer catheter system. According to a press release, the Leaflex Performer is a transfemoral catheter...

Signal that left radial access reduces the risk of PCI-related stroke

A new study shows that patients who undergo percutaneous coronary intervention (PCI) via left radial access have a similar risk of in-hospital/30-day mortality, major...

CoreValve shows “favourable performance” at long-term follow-up

Erik W Holy (Heart Center, Segeberger Kliniken, Bad Segeberg, Germany) and others report in EuroIntervention that the CoreValve self-expanding transcatheter aortic valve implantation (TAVI)...

Cardiac Dimensions appoints Matthew Stark as vice president of Clinical and...

Cardiac Dimensions has appointed Matthew Stark as vice president of clinical and regulatory affairs, and has also appointed Trevor Moody to its board of...

Japan’s Ministry of Health Labour and Welfare grants national reimbursement for...

Abbott has announced that Japan’s Ministry of Health Labour and Welfare (MHLW) has granted national reimbursement for Xience Sierra, the newest generation of the...

Only 16% of patients participate in a formal exercise programme after...

According to a study published in Circulation, among more than 230,000 cardiac patients who had sustained a myocardial infarction or undergone one of two...

Cardioband becomes first-ever transcatheter tricuspid system to receive the CE mark

Edwards Lifesciences has received the CE mark for the Cardioband tricuspid valve reconstruction system for the treatment of tricuspid regurgitation. The approval means that...

SCAI 2018: David A Cox becomes Society’s new president

David A Cox, (Brookwood Baptist Health, San Antonio, USA; Cardiovascular Associates of the Southeast, Birmingham, USA) has assumed office as 2018–19 president of...

SCAI 2018: 3D model could be used to predict paravalvular leak...

A new study presented at the 2018 Society for Cardiovascular Angiography and Interventions (SCAI) Scientific Sessions (25–28 April, San Diego, USA) indicates 3D printing...

Ticagrelor may be an effective tool for suppressing platelet reactivity after...

Speaking at the 2018 CRT meeting (3–6 March, Washington, DC), Victor Alfonso Jiménez Díaz (Cardiovascular Research Unit, Cardiology Department, Hospital Alvaro Cunqueiro University Hospital of Vigo,...

Non-emergent, uncomplicated target lesion revascularisation significantly increases mortality

Patients who require non-emergent, uncomplicated target lesion revascularisation after percutaneous coronary intervention (PCI) have a significantly increased risk of mortality compared with patients who...

TMVI in inoperable patients is feasible but mortality high at one...

One-year outcome data for transcatheter mitral valve implantation (TMVI), in inoperable patients, indicate most patients who survive the first 30 days after the procedure...

Terumo receives CE mark for Ultimaster Tansei drug-eluting stent

Terumo has received the CE mark for its Ultimaster Tansei drug-eluting stent. Building on the Ultimaster stent, a press release reports, the Ultimaster Tansei features optimised...

Take care from start to finish: Avoiding radial artery occlusion

Root cause analysis of radial occlusion points to vessel trauma. An ultrasound study by Costa et al demonstrated that in the setting of a...

TAVI is increasingly seen as the preferred approach for aortic valve...

A review of the trends in the use and propensity-matched analysis of in-hospital outcomes, published in Circulation: Cardiovascular Interventions, indicates that the number of...

From the heart of the Andes to the hearts of children

Roberto Canessa is one of 16 survivors from Uruguayan Air Force Flight 571, which crashed into the Andes Mountains on 13 October 1972. He...

Study to explore shortest-ever duration of triple therapy after PCI

The COBRA REDUCE trial is exploring the safety and efficacy of prescribing dual antiplatelet therapy (DAPT) for just two weeks in high bleeding risk...

Intravascular lithotripsy: A novel technology for treating calcified coronary stenoses

Intravascular lithotripsy, or IVL (Shockwave), is a novel procedure that is designed to deliver localised pulsatile sonic pressure waves, modifying calcified lesions in a...

Boston Scientific successfully opposes Edwards Lifesciences Corporation’s European patent EP 2,399,550...

According to a press release, Boston Scientific has, along with several other opponents, successfully opposed Edwards Lifesciences Corporation's European patent EP 2,399,550 (550) in...

CE mark for HeartStitch’s transapical access and closure device

A press release reports that HeartStitch transapical access and closure device provides safe and effective percutaneous transapical access for structural heart procedures and reliable...

Medtronic appoints Laura Mauri as vice president, Global Clinical Research &...

Medtronic has announced that Laura Mauri—interventional cardiologist and clinical researcher at the Brigham and Women's Hospital, and professor of medicine at Harvard Medical School—will...

Women are still less likely to receive high-intensity statin therapy after...

New data show that, after a myocardial infarction, significantly fewer women than men fill a prescription for high-intensity statin therapy. These findings are despite...

Location of tricuspid regurgitation predicts procedural success of percutaneous edge-to-edge repair

Supporting the results of previous studies, a new study indicates that percutaneous edge-to-edge repair (MitraClip, Abbott) is a feasible approach for high-risk patients with...

A third of patients do not disclose their use of complementary...

A new study indicates that just over a third of patients with cardiovascular disease use some form of complementary therapy. Furthermore, of these patients,...

GUIDE-HF trial to evaluate whether CardioMEMS can improve survival and quality...

Abbott has initiated the landmark GUIDE-HF clinical trial using the CardioMEMS HF system. The GUIDE-HF trial will study whether the CardioMEMS device can improve...

Abiomed receives FDA approval for Impella CP with SmartAssist and Optical...

Abiomed has received US FDA premarket approval (PMA) for its Impella CP heart pump with SmartAssist, using an optical sensor. At the forefront of innovation, according...

US FDA approves Cardioform septal occluder for PFO closure to prevent...

Following the results of the Gore REDUCE clinical study, which found that closure of patent foramen ovale (PFO) can prevent recurrent ischaemic strokes, Gore...

New trial of Symplicity Spyral approved

Medtronic has announced US FDA approval to begin an investigational device exemption (IDE) pivotal trial to evaluate its Symplicity Spyral renal denervation system in...

Study of next-generation JenaValve device completes enrolment

A press release reports that successful patient enrolment in the CE mark study of the next-generation JenaValve pericardial transcatheter aortic valve implantation (TAVI) system—using...

CIT 2018: BIOFLOW-VI confirms non-inferiority of Orsiro to Xience

Nine and 12-month data for Orsiro—presented by Yang Yue Jin (Fu-Wai Hospital, National Center of Cardiovascular Disease, Beijing, China) at the China Interventional Therapeutics...

Enrolment complete in CT imaging substudy of leaflet mobility with Sapien...

Edwards Lifesciences has announced that enrolment is complete in the computed tomography (CT) imaging substudy within the PARTNER 3 trial of the Sapien 3...

First two patients enrolled in early feasibility study of second-generation Colibri...

Colibri Heart Valve has announced that the first two patients have been successfully enrolled in a clinical early feasibility study of its second-generation ready-for-use...

UK Court of Appeal dismisses Edwards Lifesciences’ appeal against Sapien 3...

Acurate neo Boston Scientific has announced the UK Court of Appeal  dismissed Edwards Lifesciences’ appeal and upheld a prior court decision that Edwards’...

Rome hospital to participate in European DuraGraft registry

The European Hospital in Rome has become the first site in Italy to participate in the DuraGraft European Registry clinical trial. The registry will...

Justin Davies

Justin Davies (Imperial College London, London, UK) has always been interested in computer programming and science and has combined these two passions in his...

More non-cardiac death explains higher rate of post-PCI mortality in females

According to a new study, the higher rate of all-cause mortality after percutaneous coronary intervention (PCI) in females relates to an excess of non-cardiac...

Evidence of substance abuse found in 10% of young myocardial infarction...

Data from the YOUNG-MI registry indicate that 10% of young myocardial infarction patients (≤50 years) have cocaine and/or marijuana in their system. These findings...

Determining valve durability in the era of TAVI

Transcatheter aortic valve implantation (TAVI) has progressed from being a procedure that was solely reserved for patients who were too high risk for surgery...

ACC 2018: Short-term DAPT after PCI in acute coronary syndrome patients...

Data from the SMART-DATE study indicate that acute coronary syndrome patients who receive short-term (six months) dual antiplatelet therapy (DAPT) after percutaneous coronary intervention...

ACC 2018: Morphologic characteristics may determine benefit of percutaneous PFO closure

A new study—presented at the American College of Cardiology (ACC) Scientific Session (10–12 March, Orlando, USA) and published in the Journal of the American...

ADVERTORIAL: “All patients” should receive cerebral protection when undergoing TAVI procedures

Data indicate that patients who undergo TAVI with the Sentinel Cerebral Protection System (Claret Medical) have a significantly higher rate of stroke-free survival than...

Enrolment complete in BIOSTEMI study

Biotronik has announced that patient enrolment for the BIOSTEMI study has been completed. A press release explains that BIOSTEMI—a randomised, controlled superiority study—is the...

ACC 2018: Using iFR over FFR saves US$896 per patient per...

Economic data from the DEFINE FLAIR clinical trial indicate that using instantaneous wave-free ratio (iFR) provides one-year average cost savings of US$896 per patient...

ACC 2018: Five-year data for CoreValve show strong haemodynamic performance

New data from the CoreValve US Pivotal Extreme Risk Study and the real-world NOTION trial (Nordic aortic valve intervention Trial)—both of which examined patients...

FDA approves the world’s smallest mechanical heart valve

The US FDA has approved the Masters HP 15mm rotatable mechanical heart valve (Abbott), which a press release says is the world’s smallest mechanical...

ACC 2018: Four-step protocol improves outcomes in STEMI patients and eliminates...

Woman patient
Umesh Khot (Cleveland Clinic, Cleveland, USA) and colleagues found that implementing a four-step protocol for managing ST-segment elevation myocardial infarction (STEMI) not only improved...

ACC 2018: Alirocumab reduces cardiovascular events in high-risk patients

The ODYSSEY OUTCOMES trial met its primary endpoint, demonstrating that high-risk patients who received alirocumab (Praluent, Sanofi) on top of their maximally-tolerated statin dose...

ACC 2018: C Michael Valentine become new president of the American...

C Michael Valentine is the new president of the American College of Cardiology (ACC), officially assuming his role at the end of the 2018...

Sapphire II PRO becomes US’s first and only 1mm coronary balloon

Cardiovascular Systems has announced that the US FDA has granted 510(k) clearance for the OrbusNeich 1mm Sapphire II PRO coronary balloon. The approval means...

HeartFlow enters into licensing agreement with Cedars-Sinai for AutoPlaque technology

HeartFlow has entered into a licensing and technology transfer agreement with Cedars-Sinai in Los Angeles (USA) for AutoPlaque technology—a software tool used to detect...

Cardiogenic shock patients would benefit the most from reducing contact-to-balloon time

Data from the FITT-STEMI (Feedback intervention and treatment times in ST-segment elevation myocardial infarction) trial indicate that reducing the time between first medical contact...

“Favourable” in-hospital outcomes for younger patients undergoing TAVI

Registry data for younger patients—under 75 years—undergoing transcatheter aortic valve implantation (TAVI) is associated with similar in-hospital outcomes to propensity-matched patients undergoing surgical aortic...

Myocardial infarction patients may benefit from having anxiety

Karl-Heinz Ladwig (Technical University of Munich and Helmholtz Zentrum München, Munich, Germany) and his fellow investigators have found that anxiety may be an effective...

CE mark for 2.5mm Fantom Encore bioresorbable scaffold

According to a press release, Reva Medical has received the CE mark for its 2.5mm Fantom Encore bioresorbable scaffold and that the scaffold has...

New “Corrie” app may reduce readmissions after myocardial infarction

According to a study presented at the American College of Cardiology’s Cardiovascular Summit (22–24 February, Las Vegas, USA), a new smartphone app may help...

Following FDA approval, Resolute Onyx 2mm becomes smallest stent on US...

Designed specifically for small vessels, the Resolute Onyx 2mm drug-eluting stent has received US FDA approval and, consequently, has been launched on to the...

Cardiovascular News Issue 48—March 2018 US edition

In this edition of Cardiovascular News (issue 48, US edition), we report on the top stories from TCT 2017—including: ORBITA, CULPRIT-SHOCK and the cost-effectiveness data from...

Cardiovascular News Issue 48—March 2018

In this edition of Cardiovascular News (issue 48), we report on the top stories from TCT 2017—including: ORBITA, CULPRIT-SHOCK and the cost-effectiveness data from...

Edwards’ self-expanding Centera TAVI valve now on European market

Edwards Lifesciences has received the CE mark for its self-expanding Centera transcatheter aortic valve implantation (TAVI) valve for severe, symptomatic aortic stenosis patients at...

Short-term DAPT is feasible for patients undergoing percutaneous LAA closure

Felix Weise (Cardioangiologisches Centrum Bethanien, Frankfurt, Germany) and others report in EuroIntervention that a strategy of six weeks’ duration of dual antiplatelet therapy (DAPT)...

New-onset atrial fibrillation after CABG significantly increases the risk of death...

New data from the EXCEL trial, which found that percutaneous coronary intervention (PCI) was non-inferior to coronary artery bypass grafting (CABG) at three years...

Fifty US centres are now using Claret Medical’s Sentinel cerebral protection...

Since it received FDA clearance in June 2017, the Sentinel cerebral protection system (Claret Medical) has become an emerging standard of care in the...

Abiomed receives expanded FDA approve for high-risk PCI procedures

Abiomed has received an expanded US FDA premarket approval for the Impella 2.5 and Impella CP heart pumps during elective and urgent high-risk percutaneous coronary...

First patient enrolled in trial reviewing 28-day DAPT with Xience

The first patient has been enrolled in a clinical trial evaluating 28 days of dual antiplatelet therapy (DAPT) in patients at high risk of...

LivaNova to buy TandemLife

LivaNova has entered into an agreement to acquire TandemLife, a privately held company focused on advanced cardiopulmonary temporary support solutions. A press release reports...

Patient enrolment at UK sites of European DuraGraft registry initiated

Somahlution has announced that Golden Jubilee National Hospital and Victoria Blackpool Hospital in the UK have initiated patient enrolment in the DuraGraft European registry...

American College of Cardiology expand programme to lower readmission rates after...

According to an American College of Cardiology (ACC) press release, hundreds of hospitals across the USA will have access to tools and resources to...

Ticagrelor significantly reduces the risk of MACE in myocardial infraction patients...

A new subanalysis of the phase III PEGASUS-TIMI 54 trial indicates that ticagrelor (Brilique, AstraZeneca), in combination with low-dose aspirin, is associated with a ...

BioVentrix now has 2018 NUB Reimbursement Status 1 in Germany for...

BioVentrix has announced a significant reimbursement achievement. InEk, the German Institute for Hospital Remuneration, has reconfirmed the award of NUB Status 1 for the...

ISET 2018: OPTALYSE PE trial reinforces safety and efficacy of EKOS...

BTG reported that the OPTALYSE PE one-year trial results, presented at ISET (3–5 February, Hollywood, USA), confirm that bilateral pulmonary embolism patients treated in...

Stress response may be reason for link between traffic noise and...

Thomas Munzel (Department of Internal Medicine, University Medical Center Mainz, Johannes Cutenberg University, Mainz, Germany) and others report in the Journal of the American...

Siemens Healthineers and Circle Cardiovascular Imaging announce joint development plan for...

At the 2018 Joint EuroCMR/SCMR meeting (31 January–3 February, Barcelona, Spain), which brings together top clinicians and researchers within the cardiovascular and MRI communities,...

More than 185 million patients now have access to HeartFlow FFRct

HeartFlow has revealed that seven new commercial payers issued positive medical policies covering the use of the HeartFlow FFRct analysis following a coronary computed...

Depression significantly increases mortality after aortic valve replacement

Data from the FRALITY-AVR (Frality aortic valve replacement) study suggest that the presence of depression in patients undergoing aortic valve replacement—either via surgery or...

Laboratory-confirmed influenza significantly increases the risk of acute myocardial infarction

Jeffrey C Kwong (Institute for Clinical Evaluative Sciences, Toronto, Canada) and others report in The New England Journal of Medicine that patients with laboratory-confirmed...

Key interventional cardiologists come together to form medical advisory board for...

Robocath—a company that conceives and develops cardiovascular robotic systems for the treatment of vascular diseases—has announced the creation of its medical advisory board, including...

US FDA grants BioCardia IDE approval for the CardiAMP chronic myocardial...

BioCardia has announced that the US FDA has approved an investigational device exemption (IDE) for the CardiAMP chronic myocardial ischaemia (CMI) trial to treat...

First patient enrolled in Tryton post-approval study

According to a press release from Tryton Medical, the first patient has been enrolled in the post approval study to evaluate the Tryton side-branch...

Corindus Vascular Robotic to co-sponsor courses on transradial coronary interventions

Corindus Vascular Robotics will be co-sponsoring courses at multiple leading hospitals to educate interventional cardiologists on transradial access techniques and robotic-assisted vascular interventions. The course...

Telemark microcatheter receives US FDA approval

Surmodics has received US FDA 510(k) clearance for its Telemark .014inch coronary support microcatheter. A press release reports that the company is making the...

Patients who have an in-hospital cardiac arrest at the weekend continue...

Woman patient
Uchenna R Ofoma (Geisinger Health System, Danville, USA) and others report in the Journal of the American College of Cardiology that patients who have...

Boston Scientific enters into an acquisition option agreement with Millipede

Boston Scientific has closed an investment and entered into an acquisition option agreement with Millipede, which has developed the “IRIS” transcatheter annuloplasty ring system...

Japanese Ministry of Health approve Biotronik’s Orsiro drug-eluting stent

According to a Biotronik press release, the Japanese Ministry of Health has approved the company’s Orsiro coronary stent—a sirolimus-eluting stent with a biodegradable polymer—for...

ESC 2018: Society calls for abstract submissions for its next congress

The European Society of Cardiology (ESC) has released a new video, see below, that outlines the reasons why physicians should consider submitting an abstract...

Prediabetes significantly increases risk of events after PCI

An all-comers study of patients undergoing percutaneous coronary intervention (PCI) with contemporary drug-eluting stents indicates that those with prediabetes have a significantly higher risk...

Next-day discharge appears safe for TAVI patients without in-hospital complications

Patients who undergo transfemoral transcatheter aortic valve implantation (TAVI) with a minimalist approach and who are discharged the day after the procedure have similar...

First US commercial implants of Elunir drug-eluting stent performed

Cordis and Medinol have announced that the first US commercial cases using the Elunir drug-eluting stent have taken place at New York-Presbyterian Hospital/Columbia University...

Mayo Clinic using robot-assisted PCI for preclinical study on “telestenting”

Corindus Vascular Robotics has announced that it is working with Mayo Clinic in a preclinical study about use of telestenting. A press release reports...

First patient enrolled in OPTIMIZE study of Svelte drug-eluting stent integrated...

The Christ Hospital, Lindner Research Center in Cincinnati, USA, has enrolled the first patient in Svelte Medical System’s OPTIMIZE clinical study; the study is...

Second myocardial infarction twice as likely to occur non-culprit artery than...

The results of PRECLUDE, an analysis of data from the ongoing SWEDEHEART quality registry, show that in people with multivessel disease, the risk of...

First-in-human implantation of the Cordella pulmonary artery pressure sensor performed

Endotronix has announced successful first-in-human implantation of the Cordella pulmonary artery pressure sensor and the initiation of the SIRONA first-in-human (FIH) clinical trial. Wilfried...

Acarix announces start of multicentre trial for handheld CADScor system

Acarix started the initiation of a multicentre trial of its handheld CADScor system, which is designed to provide non-invasive, non-radiation acoustic detection of coronary...

Sixty-day follow-up for the MANTA US pivotal trial completed

Essential Medical has announced the completion of the 60-day follow up for its MANTA US pivotal study. Manta is vascular closure device and is...

Team-centred approach is best way of determining need for PFO closure

A meta-analysis, published in The American Journal of Medicine, provides further evidence that percutaneous closure of patent foramen ovale (PFO) in patients with recent...

Miracor Medical raises €25M to support clinical and prepare commercial activities

Miracor Medical Systems and Miracor Medical have announced the closing of € 25m as part of a Series D financing round. The new capital...

Recommendations for the use of embolic protection devices during saphenous vein...

A meta-analysis—published in Circulation Cardiovascular Interventions—indicates that the routine use of an embolic protection device during percutaneous coronary intervention (PCI) in a saphenous vein...

Modifying procedural technique during TAVI may lower radiation exposure to patients

Andrew Goldsweig (Division of Cardiology, University of Nebraska Medical Center, Omaha, USA) and others report in Catheterization and Cardiovascular Interventions that eight factors are...

Promising results for RenalGuard in heart failure patients

According to a press release, a first-in-man feasibility study focusing on a novel use of the RenalGuard system to manage fluids during diuretic therapy...

London’s Science Museum honours 50 years of heart transplants

The Science Museum (London, UK) has unveiled a special exhibit to commemorate the 50th anniversary of the world’s first heart transplant, which took place...

Health Care Service Corporation deem that FFRCT may be a “medically...

HeartFlow has announced that the Health Care Service Corporation (HCSC)—that operates Blue Cross and Blue Shield plans in Illinois, Montana, New Mexico, Oklahoma and...

Janssen seeks approval for rivaroxaban to be used to reduce cardiac...

Janssen has submitted a supplemental new drug application to the US FDA for two new indications for rivaroxaban (Xarelto, which is marketed by Bayer in...

Apple and Stanford Medicine launch app-based arrhythmia study

Apple has launched the Apple Heart Study app, a first-of-its-kind research study using Apple Watch’s heart rate sensor to collect data on irregular heart rhythms and...

M Lewis Kinard appointed as executive vice president, general counsel and...

The American Heart Association (AHA) has named attorney M Lewis Kinard as executive vice president, general counsel and assistant corporate secretary for the organisation...

Philips acquires cloud-based population health management solution provider VitalHealth

Philips has acquired VitalHealth, a provider of cloud-based population health management solutions for the delivery of personalised care outside of the hospital. Headquartered in...

ICI 2017: Novel transcatheter mitral valve wins Best Technology Parade Presentation

4C Medical Technologies has won the Best Technology Parade Presentation award—at  the 2017 Innovations in Cardiovascular Interventions (ICI) meeting (3–5 December, Tel Aviv, Israel)—for...

Acute iFR evaluation may be a valid approach for ruling out...

The iSTEMI study, published in JACC: Cardiovascular Interventions, suggests that instantaneous wave-free ratio (iFR) in the acute setting—ie. immediately after successful primary percutaneous coronary...

Pollution may derail benefits of walking in older adults

Fan Chung (National Heart & Lung Institute, Imperial College London, UK) and colleagues report in The Lancet that even short-term  (two-hour) exposure to tiny...

Global survey indicates that patients with type 2 diabetes underestimate their...

According to the interim results of the first-ever multi-country online survey on cardiovascular disease risk awareness and knowledge among people living with type 2...

“Vast majority” of young myocardial infarction patients do not meet criteria...

Avinainder Singh (Brigham and Women’s Hospital, Harvard Medical School, Boston, USA) and others report in the Journal of the American College of Cardiology that...

STEMI patients at highest risk are less likely to receive optimal...

Data from the regional emergency cardiovascular (RESCUe) network indicate that patients who have had a ST-segment elevation myocardial infarction (STEMI) and who are increased...

EpicHeart soft-robotic heart assist device wins innovation award

CorInnova has been awarded second prize in the “2017 InnoSTARS” life science competition for its EpicHeart soft-robotic heart assist device. The on-blood-contacting device is...

TCT 2017: The HREVS study provides supportive evidence for the hybrid...

The HREVS (Hybrid coronary revascularisation vs. standard) trial found that there was no significant difference between percutaneous coronary intervention (PCI), coronary artery bypass grafting...

TCT 2017: FAME 2 provides support for PCI in stable disease...

Following ORBITA, which indicated percutaneous coronary intervention (PCI) did not provide benefit over a sham procedure in patients with stable coronary artery disease, the...

Evolocumab becomes first PCSK9 inhibitor to be approved for use in...

The US FDA has approved evolocumab (Repatha, Amgen) for the prevention of myocardial infarction, strokes and coronary revascularisations in adults with established cardiovascular disease....

TCT 2017: Advances in device technology needed to improve outcomes with...

Data from the ABSORB IV study indicate that device thrombosis with the bioresorbable vascular scaffold (Absorb, Abbott) is substantially reduced when the device is...

Artificial intelligence is being explored as a new tool for diagnosing...

We are witnessing a new era in which artificial intelligence is being applied to areas of research, imaging, diagnostics, and treatment. In cardiovascular medicine,...

Report calls for US to prioritise health resources towards diagnosing and...

A report—modified from US global health recommendations from the National Academies of Sciences, Engineering and Medicine (previously the Institute of Medicine) and published in...

Elunir drug-eluting stent approved for use in the USA

Cordis and Medinol have announced that the US FDA has approval the Elunir drug-eluting stent for the treatment of patients with coronary artery disease....

Inhaled Xenon plus hypothermia may reduce myocardial injury after an out-of-hospital-cardiac...

NeuroproteXeon has announced the publication of a second finding from a randomised, controlled phase II trial of inhaled xenon and oxygen, combined with hypothermia,...

China’s first human implantation of a retrievable TAVI device successfully completed

The first human implantation of the VenusA Plus retrievable valve system was completed successfully at the Second Affiliated Hospital of Zhejiang University School of...

“We really believe that the transradial approach is a better way...

The Society for Cardiovascular Angiography and Interventions (SCAI) has launched a new initiative, supported by Medtronic, called “Transition for value” that aims to help...

Interventional cardiology in the Twitterverse

The past few years has witnessed increasing clinician engagement with social media platforms, including Twitter (which, overall, has 300 million active users). Well-known “Tweeters”...

Boston Scientific pushes back plans for commercialisation of Lotus Edge TAVI...

Boston Scientific has announced a delay to the previously communicated timelines for the commercialisation of its Lotus Edge transcatheter aortic valve implantation (TAVI) device...

US patients have had more preventive care for cardiovascular disease under...

Joseph Ladapo (David Geffen School of Medicine, University of California, Los Angeles, USA) and others report in American Journal of Managed Care that—by reducing...

TCT 2017: TMVI in mitral ring is a reasonable alternative for...

Data from the MITRAL (Mitral Implantation of Transcatheter valves) study indicate that transeptal transcatheter mitral valve implantation (TMVI), with a Sapien 3 device (Edwards...

TCT 2017: Vivek Reddy on the final outcomes of PREVAIL and...

Boston Scientific has announced the final five-year outcomes data from the PREVAIL study during a late-breaking clinical trial session at this year’s Transcatheter Cardiovascular Therapeutics (TCT;...

Francesco Maisano

Francesco Maisano (University Heart Centre, University Hospital Zurich Zurich, Switzerland) works on the border between surgery and interventions; he embraces heart team challenges and...

AHA 2017: Widely used approach for preventing renal complications after angiography...

Data from PRESERVE (Prevention of serious adverse events following angiography) indicate that neither intravenous sodium bicarbonate nor acetylcysteine, compared with saline and placebo, reduce...

AHA 2017: Novel transcatheter therapy for heart failure shows promise in...

Primary results from the REDUCE LAP-HF trial indicate that a novel interatrial shunt device (IASD, Corvia Medical) significantly reduced pulmonary capillary wedge pressure (PCWP)...

Creavo wins two awards for its cardiac imaging device

Creavo's Vitalscan
  Creavo Medical Technologies (Creavo) has won two awards at the Institution of Engineering and Technology (IET) Innovation awards (15 November, London, UK) for its...

A bold new study could alter the orbit of elective PCI

The ORBITA (Objective randomised blinded investigation with optimal medical therapy of angioplasty in stable disease) study, recently presented at 2017 Transcatheter Cardiovascular Therapeutics (TCT)...

AHA 2017: Nutty eating habits may lower the risk of cardiovascular...

A study published in the Journal of the American College of Cardiology indicates that people who regularly eat nuts—including peanuts, walnuts and tree nuts...

AHA 2017: First patients enrolled in trial of IASD system for...

Corvia Medical has enrolled the first patients in its global multicentre trial (REDUCE LAP-HF II) of the interatrial shunt device (IASD) for the treatment...

Precommercialisation of Serpentis drug-eluting stent announced

Stentys has announced the precommercialisation of its Serpentis stent. According to a press release, the sirolimus-eluting stent has a biodegradable coating and is designed...

New study shows significant clinical workflow and staff experience benefits of...

Philips has announced the results of a comprehensive, independent, two-year study demonstrating the clinical workflow benefits of its next generation image-guided therapy platform, Azurion. The...

AHA 2017: Fun in the bedroom is unlikely to cause a...

Data published, as a research letter, in the Journal of the American College of Cardiology and presented at the American Heart Association’s Scientific Sessions...

Neovasc receive approval to initiate COSIRA-II IDE clinical trial

Neovasc has received approval of the US FDA to initiate the COSIRA-II IDE clinical trial.  The trial's purpose will be to demonstrate the safety...

TCT 2017: Sham-controlled trial raises doubts about benefit of angiography-guided PCI...

ORBITA (Objective randomised blinded investigation with optimal medical therapy of angioplasty in stable disease)—the first-ever sham controlled trial of percutaneous coronary intervention (PCI)—indicates that...

TCT 2017: Study challenges recommendations on the management of cardiogenic shock

Advice on percutaneous coronary intervention (PCI) strategies for patients with acute myocardial infarction complicated by cardiogenic shock may need to be revised after the...

MitraClip becomes first approved device for transcatheter mitral valve repair in...

Abbott has announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved its MitraClip device for treatment of people with mitral regurgitation....

Centers for Medicare and Medicaid Services finalise a new technology ambulatory...

HeartFlow has announced that the Centers for Medicare & Medicaid Services (CMS) has finalised a new technology ambulatory payment classification (APC) for the HeartFlow...

TCT 2017: Elixir reveals new drug-eluting stent

Elixir Medical unveiled for the first time its novel stent technology—Dynamx—at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 October–2 November, Denver, USA). A...

TCT 2017: Pooled analysis of Magmaris studies continue to show no...

Data presented during the 2017 Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 October–2 November, Denver, USA), according to a press release, provide further evidence of...

TCT 2017: Next-generation FFR system launched

Acist has announced the global launch of its RXi Mini system—the next-generation system of its RXi Rapid Exchange fractional flow reserve (FFR) system. The...

TCT 2017: No advantage with extending dual antiplatelet therapy beyond six...

The primary results from the DAPT-STEMI trial suggest that 12-month dual antiplatelet therapy (DAPT) is not superior to six-month DAPT in patients who have...

TCT 2017: Fantom bioresorbable scaffold continues to show positive outcomes at...

The Fantom bioresorbable scaffold (Reva Medical) shows continued positive clinical outcomes according to an interim data set from the FANTOM II clinical trial, which...

TCT 2017: Two studies support feasibility of transcatheter mitral valve implantation

Early experiences with two transcatheter mitral valve implantation (TMVI) devices—Intrepid (Medtronic) and the Tendyne mitral valve (Abbott)—indicate that TMVI may be a safe and...

TCT 2017: No role for bare metal stents to reduce duration...

Olivier Varenne (Hôpital Cochin, Assistance Publique—Hôpitaux De Paris, Paris, France) reported that the strategy of using bare metal stents to enable a shorter duration...

TCT 2017: TAVI “should be the preferred strategy” for patients at...

David Cohen (Saint Luke’s Mid America Heart Institute, Kansas City, USA) has suggested that, on basis of both clinical and economic considerations, transcatheter aortic...

TCT 2017: New data for CoreValve Evolut further support its use...

New clinical research, presented today at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 October- 2 November, Denver, USA), support the positive clinical performance...

TCT 2017: Combo dual-therapy stent is non-inferior to Xience at one...

New results from the HARMONEE Japan/US registration trial, which were presented yesterday at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 October – 2...

Xience Sierra is now on European market

The CE mark has been awarded to a new-generation of Abbott Vascular's everolimus-eluting, metallic stent Xience. The Xience Sierra, according to a press release,...

TCT 2017: Data for novel cardiac imaging technology unveiled

New data from the ongoing CADLAD (Coronary artery disease learning and algorithm development) study will be presented at the 2017 Transcatheter Cardiovascular Therapeutics (TCT)...

TCT 2017: AI-driven cardiac ultrasound company to give two presentations

Bay Labs, a medical technology company developing an artificial intelligence in cardiovascular imaging, has announced that its chief medical officer Randolph P Martin (Emory...

First year after a myocardial infarction poses more risks for women

Woman patient
A team at the Technical University of Munich (TUM) has determined that in the first year after a myocardial infarction, women are subject to...

US FDA 510(k) clearance for its Nova Cross Extreme and Nova...

Nitiloop has received FDA clearance for its new Nova Cross Extreme and Nova Cross BTK. These dedicated microcatheters are joining the Nova Cross product...

Cobra PzF nano-coated stent now being studied with 14-day DAPT in...

The US FDA has approved the expansion of CeloNova’s ongoing clinical trial of its proprietary Cobra PzF nano-coated stent to enable the use of...

Heart valve replacement surgery may not be a morning procedure

David Montaigne (University of Lille, France) and others report in The Lancet that performing heart valve replacement in the afternoon was associated with better...

Controlling blood pressure may help to prevent mitral regurgitation

A new study indicates that long-term exposure to elevated blood pressure is associated with an increased risk of primary and secondary mitral regurgitation. According...

Non beta-blocker therapies are infrequently used in patients experiencing angina after...

Data from the TRANSLATE-ACS (Treatment with adenosine diphosphate receptor inhibitor: longitude assessment of treatment of patterns and events after acute coronary syndrome), published in...

Combing intravascular ultrasound with multispectral fluorescence lifetime imaging may provide comprehensive...

In Scientific Reports, a Nature publication, Julien Bec (Department of Biomedical Engineering, University of California Davis, Davis, USA) and others write that the combination...

TCT 2017: Boston Scientific reveals presentations at conference

Boston Scientific has announced key data will be presented at next week’s Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 October–2 November, Denver, USA). For example,...

Claret Medical closes on series C financing of US$14.5m

Claret Medical has announced that it has closed on a series C financing of US$14.5m led by Lightstone Ventures, with participation from existing investors...

First patient implanted with Intrepid TMVI device in APOLLO trial

The first patient in the APOLLO trial has undergone transcatheter mitral valve implantation (TMVI) with the Intrepid device (Medtronic). The study—the first-ever pivotal trial...

Second successful implant of minimally invasive annuloplasty system announced

Micro Interventional has announced that the second successful implantation of its minimally invasive annuloplasty (MIA) technology. The patient was enrolled in the first arm...

Boston Scientific advert

Everolimus-Eluting Platinum Chromium Coronary Stent System Drug-eluting stent technology with a durable polymer has shown encouraging efficacy compared with bare metal stents, significantly reducing restenosis...

Myocardial infarction survivors more likely to use “emotion-focused” strategies to cope...

Data presented at the 8th Emirates Cardiac Society congress (19–21 October, Dubai, UAE), which is held in collaboration with the American College of Cardiology...

“Neurocardiologists” could treat acute ischaemic stroke patients when a neurointerventionalist is...

Thomas Haldis (Sanford Health, Fargo, USA) and others report in EuroIntervention that interventional cardiologists, as “neurocardiologists”, can be trained to perform mechanical thrombectomy safely and...

Fantom bioresorbable scaffold implanted for first time in Switzerland

Reva Medical has announced the commercial expansion of its bioresorbable scaffold Fantom, with the first implantation of the device in Switzerland. The procedure was...

TCT 2017: Elixir Medical to reveal “a game-changing metallic drug-eluting stent...

Elixir Medical has revealed details of its programme and activities during the 2017 meeting of the transcatheter cardiovascular therapeutics (TCT; 29 October–2 November, Denver,...

Cardiology societies come together to provide new assessment options for subspecialities

The American College of Cardiology (ACC), Heart Failure Society of America (HFSA), Heart Rhythm Society (HRS) and Society for Cardiovascular Angiography and Interventions (SCAI)...

Coronary angiography after TAVI with a self-expanding valve is challenging but...

A new study indicates that coronary angiography, with or without percutaneous coronary intervention (PCI), is feasible in patients who have undergone transcatheter aortic valve...

Creavo Medical Technologies receives US FDA 510(k) approval for Vitalscan

The US FDA has granted 510(k) clearance to Creavo Medical Technologies for its portable scanning device, Vitalscan. A press release reports that the move opens...

Relatively few chronic kidney disease patients require dialysis after TAVI

James W Hansen (Lahey Hospital and Medical Center, Burlington, USA) and others report in JACC: Cardiovascular Interventions that the number of patients with chronic...

US doctors urged to take action on gun violence

Garen Wintemute (Violence Prevention Program, University of California Davis, USA), in an editorial in the Annals of Internal Medicine, has called for physicians to...

PCRLV 2017: New ESC guidelines for valvular heart disease represent a...

Bernard Prendergast (Department of Cardiology, St. Thomas' Hospital, London, UK), in this PCR video, outlines the key points of the 2017 European Society of...

First patient enrolled in Frontier IV clinical trial of PerQseal large...

Vivasure Medical has announced the successful enrolment of the first patient in the Frontier IV clinical study, a non-randomised multicentre international trial, designed to...

TCT 2017: Alec Vahanian to receive the Master Clinical Operator award

The Geoffrey O. Hartzler Master Clinical Operator Award will be presented to Alec Vahanian (Cardiology Department, University Paris Diderot, Bichat Hospital, AP-HP, Paris, France)...

Study demonstrates feasibility and safety of RenalGuard of reducing risk of...

A first-in-man, feasibility study of the use of the RenalGuard system in patients undergoing coronary artery bypass grafting (CABG) shows the potential of RenalGuard...

CADScor system shown at the German Heart Days meeting

Acarix AB has presented its CADScor system for non-invasive, non-radiation acoustic rule-out of coronary artery disease at the German Heart Days meeting (12–14 October,...

Pamela B Morris to be next American College of Cardiology scientific...

Pamela B Morris has been selected as the next vice chair of the American College of Cardiology (ACC) annual scientific session. She will serve...

Enrolment in BIOVITESSE trial of polymer-free coronary stent initiated

Biotronik has announced the start of enrolment in a coronary stent trial aiming at assessing the safety and clinical performance of a new coronary...

Data for NobleStitch EL suture based closure system presented at CSI...

At CSI UCSF Congress, Achille Gaspardone (Hospital of Sant'Eugenio, Rome, Italy) presented a comprehensive report on closure of patent foramen ovale (PFO) and related atrial...

Thomas F Lüscher becomes director of education, research and development at...

Thomas Lüscher has been appointed director of education, research and development at Royal Brompton & Harefield NHS Foundation Trust.  A press release reports that...

EACTS 2017: Vascular Graft Solutions to hold symposium on venous external...

Vascular Graft Solutions is hosting a symposium on the future of coronary artery bypass grafting (CABG) at the European Association for Cardio-Thoracic Surgery (EACTS)...

No significant differences in post TAVI outcomes between African Americans and...

Fahad Alqahtani (Division of Cardiology, West Virginia University Heart & Vascular Institute, Morgantown, USA) and others report in Catheterization and Cardiovascular Interventions that there...

First patient enrolled in US arm of ALIVE pivotal clinical trial

BioVentrix has announced that the first patient has been enrolled in the US arm of the ALIVE pivotal clinical trial. The trial is designed...

Essential Medical completes enrolment in US IDE trial of Manta

Essential Medical has announced the completion of enrolment in the US pivotal investigational device exemption (IDE) trial of the Manta large bore vascular closure...

First procedure performed in Rox Medical’s CONTROL HTN-2 clinical trial

The first patient was treated in the CONTROL hypertension (HTN)-2 clinical study, the Rox Medical’s pivotal study to evaluate the safety and effectiveness of...

Missing out on breakfast may increase risk of atherosclerosis

A study published in the Journal of the American College of Cardiology indicates that people who do not eat breakfast have an increased risk...

Sirolimus-coated balloon “may represent a new approach to treating in-stent restenosis”

Stefan Verheye (Antwerp Cardiovascular Centere ZNA Middelheim, Interventional Cardiology, Antwerp, Belgium) and others report in JACC: Cardiovascular Interventions that the use of a sirolimus-coated...

Enrolment completed in US pivotal clinical study of Cardioform ASD Occluder

Gore has completed enrolment for the pivotal phase of its Gore ASSURED Clinical Study. This investigational device exemption (IDE) trial is researching the company’s...

PCR LV 2017: Refining implantation technique and device iterations may improve...

New data from REPRISE III indicate that keeping the bottom of the frame at annular level while implanting and targeting a final depth of...

Bioresorbable valves: Insights into a potential game-changing technology

The burden of cardiovascular mortality and morbidity is constantly increasing in Western countries and, at the same time, acquired and congenital valvular diseases are...

From SYMPLICITY HTN-1 to SPYRAL HTN-OFF MED: The story of renal...

It is now almost a decade since the first patient underwent catheter-based renal denervation as a participant in a safety and proof-of concept study...

Philippe Généreux appointed chief medical officer of Saranas

Saranas has announced the appointment of Philippe Généreux as its chief medical officer. Généreux is the co-director of the Structural Heart Disease Program at...

Optiflow arterial cannulae family launched onto the USA

LivaNova has received FDA 510(k) clearance for the US market launch of its Optiflow arterial cannulae family.  A press release reports that the Optiflow...

iVascular’s drug-eluting stent and drug-eluting balloon now available for sale in...

iVascular SLU has received approval for selling its coronary and peripheral products in India. Therefore, the company’s coronary drug-eluting stent, coronary dug-coated balloon, as well...

American College of Cardiology says that reforms to US healthcare come...

The president of the American College of Cardiology (ACC), Mary Norine Walsh, has said that “it is concerning” that the Graham-Cassidy proposal (for US...

FORWARD PRO clinical study to evaluate longer term performance of CoreValve...

A new post-market clinical study is to evaluate Medtronic’s CoreValve Evolut Pro transcatheter aortic valve implantation (TAVI) valve in everyday clinical practice. Studying patients...

FDA grants Abiomed pre-market approval for is Impella RP for right...

Abiomed has received FDA pre-market approval for its Impella RP heart pump. Culminating from five years of research, according to a press release, this...

Direct stenting with drug-eluting stents may be associated with better outcomes

Marco A Magalhaes (Department of Internal Medicine, MedStar Washington Hospital Center, Washington, DC, USA) and others report in Catheterization and Cardiovascular Interventions that direct...

Three studies support efficacy of PFO closure for reducing risk of...

The results of CLOSE, Gore Reduce and the extended follow-up of RESPECT—all published in The New England Journal of Medicine—indicate that percutaneous closure of...

Cancer history influences treatment of myocardial infarction

Dragana Radovanovic (AMIS Plus Data Centre, Zurich, Switzerland) and colleagues report in the European Heart Journal: Acute Cardiovascular Care that the treatment of myocardial infarction...

PCR LV 2017: The optimal modalities for imaging for mitral and...

As the field of structural heart interventions expands from the now-established transcatheter therapies for native aortic stenosis to include treatment of mitral and tricuspid...

CardiAMP Heart Failure trial to further evaluate use of regenerative therapy...

BioCardia has revealed the trial design for its pivotal Phase III CardiAMP Heart Failure Trial at the Texas Heart Institute International Symposium on Cardiovascular...

Carag completes CE marking for its breakthrough Carag bioresorbable septal occluder

Carag has announced that it has completed CE marking for its Carag bioresorbable septal occluder. A press release reports that the device is a...

FDA grants 510(k) clearance to Fysicon’s QMAPP haemodynamic monitoring system

Fysicon has announced that it has received 510(k) FDA clearance for its QMAPP haemodynamic monitoring system. A press release reports that QMAPP offers cardiologists...

All-comers data indicate stroke-free survival is improved with Sentinel embolic protection...

Jochen Wöhrle (Department of Internal Medicine II, Cardiology, University of Ulm, Ulm, Germany) and his team report in JACC: Cardiovascular Interventions that, in an...

Caucasians have a higher incidence of an out-of-hospital cardiac arrest but...

There is a lack of sufficient data about the effect of racial differences on outcomes following an out-of-hospital cardiac arrest. Therefore, Karuppiah Arunachalam and...

New meta-analysis finds RenalGuard reduces all-cause mortality in patients undergoing cardiac...

Anand Prasad (Department of Medicine, Division of Cardiology, University of Texas Health Science Center, San Antonio, USA) and others report in the Journal of...

Edwards Lifesciences’ Alterra adaptive prestent device used for first time to...

Evan Zahn (Guerin Family Congenital Heart Program, Cedars-Sinai Heart Institute, Los Angeles, USA) has become the first interventional cardiologist to implant the Alterra adaptive...

ESC 2017: Further decreasing mortality after STEMI will be difficult

According to results from the FAST-MI programme, six-month mortality after ST-segment elevation myocardial infarction (STEMI) and after non-STEMI (NSTEMI) considerably decreased between 1995 and...

ADVERT: Edwards SAPIEN 3 Transcatheter Heart Valve

JTNDbWV0YSUyMGh0dHAtZXF1aXYlM0QlMjJyZWZyZXNoJTIyJTIwY29udGVudCUzRCUyMjAlM0IlMjBVUkwlM0QlMjdodHRwJTNBJTJGJTJGd3d3LmVkd2FyZHMuY29tJTJGZ2IlMkZkZXZpY2VzJTJGSGVhcnQtVmFsdmVzJTJGVHJhbnNjYXRoZXRlci1TYXBpZW4tMyUzRnV0bV9zb3VyY2UlM0RjYXJkaW92YXNjdWxhci1uZXdzJTI2dXRtX21lZGl1bSUzRGRpc3BsYXklMjZ1dG1fY2FtcGFpZ24lM0RFZHdhcmRzX0VVXzIwMTclMjZ1dG1fY29udGVudCUzRGNhcmRpb3Zhc2N1bGFyLW5ld3NfUzNfTGlmZV9Jc19XYWl0aW5nXzYwMHg0MDAlMjclMjIlMjAlMkYlM0U= Patients. Our mission for life. Together, we can do even more than help patients. Join Edwards Lifesciences on our mission to change lives.

TCT 2017: Cardiovascular Research Foundation announces late-breaking trials and first-report investigations

The Cardiovascular Research Foundation (CRF) has release details of the 12 late-breaking trials and 16 first report investigations that are to be presented at...

Neovasc provides Tiara clinical update

Neovasc has provided an update on the study progress and clinical performance of the Tiara valve, a self-expanding mitral bioprosthesis for transcatheter implantation in...

First patient enrolled in PRECISION GRX registry

Corindus Vascular Robotics has announced that the first patient has been enrolled in its PRECISION GRX registry, which is a post-market study of its...

New literature review highlights that Perceval sutureless aortic valve is safe

Corey Adams (Health Science Center, St John’s, Canada) and others report in the latest issue of Innovations that the Perceval sutureless aortic valve (LivaNova)...

Court of Dusseldorf grants Alvimedica an injunction against A B Handels...

Alvimedica has announced that the Court of Dusseldorf (Germany) has recognised in full the CID-Alvimedica rights on intellectual properties regarding the principles and related...

ESC 2017: Post-TAVI clinical leaflet thrombosis is “infrequently reported” but is...

Of 5,691 adverse events following transcatheter aortic valve implantation (TAVI) that were reported to the FDA’s manufacturer and user facility device experience (MAUDE) database,...

ESC 2017: More evidence that supplemental oxygen in normoxic patients with...

Data from DET02X-AMI (Determination of the role of oxygen in suspected acute myocardial infarction) show that supplemental oxygen in normoxic patients with suspected myocardial...

“Low commercial sales” prompt Abbott to pull the plug on selling...

Abbott has announced that it is to stop selling its first-generation bioresorbable vascular scaffold (Absorb, Abbott Vascular) because of poor sales. The announcement follows...

Minimally invasive annuloplasty has been used to successfully perform bicuspidisation of...

Micro Interventional Devices has announced that its minimally invasive annuloplasty (MIA) technology has been successfully used for the first time to perform a tricuspid valve bicuspidisation...

ESC 2017: Alternative strategies needed for treating stenotic lesions in saphenous...

The recent DIVA (Drug-eluting stents vs. bare metal stents in saphenous vein graft angioplasty) trial, which was presented at the European Society of Cardiology...

ESC 2017: CABG is the “preferred strategy” for multivessel revascularisation in...

Data from a nationwide observational cohort study indicate that coronary artery bypass grafting (CABG) should be used instead of percutaneous coronary intervention (PCI) to...

Good care means ensuring patients are thoroughly informed

In 2010, Harlan M Krumholz wrote a commentary in the Journal of the American Medical Association (JAMA) about the need for true informed consent...

ProtEmbo cerebral protection system used for first time

The ProtEmbo cerebral protection system (Protembis) has been used, to complement a transcatheter aortic valve implantation (TAVI) procedure, for the first time in a...

American societies come together to publish appropriate use criteria for valvular...

The American College of Cardiology and several partnering societies—including the American Heart Association (AHA) and Society for Cardiovascular Angiography and Interventions (SCAI)—have released a...

Cardiovascular News Issue 46 – September 2017 US edition

To mark angioplasty’s ruby anniversary, in this issue (47; September 2017), we bring you a case report on the first-ever PCI & and review how technology...

Cardiovascular News Issue 46 – September 2017

To mark angioplasty's ruby anniversary, in this issue (47; September 2017), we bring you a case report on the first-ever PCI & and review how technology...

C Michael Gibson

C Michael Gibson (Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical, Harvard Medical School, Boston, USA) receives “instant gratification” from making a patient...

The ATI score: A new tool to triage novel treatments in...

Mechanical reperfusion via primary percutaneous coronary intervention (PCI) in combination with optimised antithrombotic therapy and antiplatelet therapy is the current gold-standard treatment for ST-segment...

The need to determine the relevance of stent malapposition

Despite a constant evolution in stent/scaffold design, stent failure is still perceived as a clinical problem. The process of drug-eluting stent struts thinning that...

Ruby anniversary: 1977 – A remarkable year for kings and queens

History was made on 16 September 1977 when Andreas Grüntzig performed world’s first in-human coronary angioplasty procedure—paving the way for percutaneous coronary intervention (PCI)...

ESC 2017: Young cardiologists discuss highlights of congress

In this video from the European Society of Cardiology (ESC), Steen Dalby Kristensen (Department of Cardiology, Aarhus University Hospital, Aarhus N, Denmark) talks to members...

Abbott’s Full MagLev HeartMate 3 LVAD receives FDA approval

The FDA has approved the Full MagLev HeartMate 3 (Abbott) left ventricular assist device for use in heart failure patients in need of short-term...

ESC 2017: MobiusHD implant shown to reduce resistant hypertension

The European results of the first-in-human trial of Vascular Dynamics’ MobiusHD implant indicate that the device is associated with a reduction in 24-hour ambulatory...

A 52mm tricuspid valve successfully implanted into a transplanted heart

The Gate catheter-guided tricuspid atrioventricular valved stent (NaviGate Cardiac Structures) has been successfully implanted through the jugular vein into a transplanted heart that was...

ESC 2017: Rivaroxaban significantly lowers risk of stroke, cardiovascular death, and...

The COMPASS study, which was presented at the European Society of Cardiology (ESC) congress (26–30 August, Barcelona, Spain), has shown that rivaroxaban (Xarelto, Bayer)...

Global agreement between Philips and HeartFlow announced

Philips and HeartFlow have announced that they have entered into a collaboration agreement with the goal of improving access to diagnostic and planning tools...

ESC 2017: Subanalysis of PEGASUS shows ticagrelor reduces cardiovascular death by...

A new subanalysis from the phase III PEGASUS-TIMI 54 trial, which was presented at the European Society of Cardiology (ESC) congress (26–30 August, Barcelona,...

US trial to evaluate safety and efficacy of Amplatzer for patent...

Abbott has initiated a US pivotal clinical study evaluating the safety and effectiveness of a modified version of its Amplatzer device to correct patent...

Several barriers need to be overcome to make “telestenting” feasible

A robotic system for performing percutaneous coronary intervention (PCI) is now clinically available and is being used routinely to perform PCI at multiple centres...

ESC 2017: Hexacath’s titanium-nitride-oxide coated stent matches Boston Scientific’s Synergy for...

During a late-breaking science session at the European Society of Cardiology (ESC) congress (26–30 August, Barcelona, Spain), Pim Tonino (Heart center Catharina Hospital, Eindhoven,...

ESC 2017: Best-practice PCI outperforms conventional PCI in patients with de...

The SYNTAX II study has found that percutaneous coronary intervention (PCI) using state-of-the-art techniques—including physiological assessment and a new-generation drug-eluting stent—significantly reduces the rate...

ESC 2017: SPYRAL HTN-OFF MED provides “proof of principle” that renal...

Results from SPYRAL HTN-OFF MED indicate that renal denervation, compared with a sham procedure, significantly reduces blood pressure in patients with hypertension who are...

ESC 2017: Significantly lower event rates with Orsiro than with Xience

  Results from the BIOFLOW V study indicate that patients who undergo percutaneous coronary intervention (PCI) using a sirolimus-eluting stent with a biodegradable polymer (Orsiro,...

ESC 2017: Case builds for dropping aspirin from triple therapy in...

The RE-DUAL PCI trial indicates that dual therapy with the non-vitamin K antagonist oral anticoagulant dabigatran (Pradaxa, Boehringer Ingelheim)—and not aspirin—and a P2Y12 inhibitor...

ADVERT: Patients have to trust that if I were in their...

PG1ldGEgaHR0cC1lcXVpdj0icmVmcmVzaCIgY29udGVudD0iMDsgVVJMPSdodHRwOi8vd3d3LmJvc3RvbnNjaWVudGlmaWMuY29tL2VuLVVTL3Byb2R1Y3RzL3N0ZW50cy0tY29yb25hcnkvYmlvYWJzb3JiYWJsZS1zdGVudC1zeXN0ZW0uaHRtbD9jaWQ9ZHNwMTc2Njg4JyIgLz4=SYNERGY™ Everolimus-Eluting Platinum Chromium Coronary Stent System Drug Eluting stent technology with durable polymer has shown encouraging efficacy compared to bare metal stents, significantly reducing restenosis...

Novel mitral regurgitation therapy featured in Innovation Summit at Cardiovascular Innovations

4C Medical Technologies has announced that its medical device therapy for mitral regurgitation was featured in the Innovation Summit at Cardiovascular Innovations (CVI) 2017...

Medtronic’s Avalus pericardial valve receives CE mark and FDA approval

Medtronic has announced CE mark and FDA approval of its new Avalus pericardial aortic surgical valve for the treatment of aortic valve disease.  According...

SHS invests in heart valve-repair start-up CoreMedic

SHS Gesellschaft für Beteiligungsmanagement is investing in CoreMedic, a start-up developing transfemoral repair systems to treat heart valve malfunctions. SHS is investing from its...

Pneumonia or sepsis increases risk of cardiovascular disease in first year...

Scott Montgomery (Örebro University, Örebro, Sweden) and colleagues report in the European Journal of Preventive Cardiology that pneumonia or sepsis in adults that results...

Absorb prompts Boston Scientific to rethink its bioresorbable scaffold programme

According to the US newspaper Star Tribune, Boston Scientific is to stop investing in its bioresorbable scaffold trial programme. The paper reports that the...

Keystone Heart accelerate trials for third-generation of its TriGuard device

Keystone Heart has announced plans to initiate clinical trials for a new, advanced version of its TriGuard cerebral embolic protection device. A press release...

CE mark for CoreValve Evolut Pro

Medtronic has received the CE mark for its CoreValve Evolut Pro valve for the treatment of severe aortic stenosis for symptomatic patients who are...

Merit Medical partners with world-renown interventional cardiologist to deliver transradial course

Merit Medical will partner with internationally renowned interventional cardiologist Ferdinand Kiemeneij to deliver the next generation in educational opportunities for interventional cardiologists and interventional...

Ruby anniversary: The key revolutions of the past 40 years

Advances in materials and techniques over the past 40 years have led to a substantial reduction in major adverse cardiovascular events. Giuliana Capretti and...

New study to evaluate safety of three-month DAPT with Xience in...

A new study, XIENCE Short DAPT, will evaluate whether three months of dual antiplatelet therapy (DAPT) is non-inferior to the standard duration of DAPT...

American College of Cardiology says it opposes US healthcare reform

The American College of Cardiology (ACC) president Mary Norine Walsh has issued a statement on upcoming Senate vote to precede to US healthcare reform...

Roxwood Medical announces agreement with Abbott for distribution of products in...

Roxwood Medical has entered into an exclusive agreement with Abbott for distribution of Roxwood products in the USA. According to a press release, the...

Black people do not have a higher rate of mortality one...

Taisei Kobayashi (Corporal Michael J Crescenz, Veterans Affairs Medical Center, Philadelphia, USA) and others report in JAMA Cardiology that—after adjustment for demographics, comorbidities and...

Orodispersible tablets of ticagrelor now available in the UK

AstraZeneca has announced the UK availability of ticagrelor (Brilique) 90mg orodispersible tablets. This follows the European Commission’s marketing authorisation of the formulation in May...

Health Canada approves a high-dose bolus regimen of tirofiban

Cardiome Pharma has announced that the Therapeutic Products Directorate of Health Canada has approved the tirofiban (Aggrastat) 25mcg/kg high-dose bolus regimen, as requested under...

Philips adds to list of recent acquisitions by buying TomTec

Philips has signed an agreement to acquire TomTec Imaging Systems GmbH, a provider of intelligent image analysis software, especially for diagnostic ultrasound. Headquartered in...

Study finds that initiatives to improve medication adherence after myocardial infarction...

Kevin G Volpp (Center for Health Incentives & Behavioral Economics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA) and others report in JAMA...

EuroPCR 2017: A “golden era” for valve disease therapies

At this year’s EuroPCR (16–19 May, Paris, France), Philip MacCarthy writes, I had the pleasure of welcoming onto the podium a team of determined cyclists...

Embolic protection device company raises US$5million in series B financing for...

Innovative Cardiovascular Solutions has announced today completion of an oversubscribed Series B round of financing totalling US$5M. The company is currently developing the Emblok...

First myocardial infarction more likely to be fatal in black people

Monika Safford (John J Kuiper Professor of Medicine and Chief of General Internal Medicine at Weill Cornell Medical College, New York, USA) and others...

CoreValve Evolut can be used to treat intermediate-risk patients in the...

Medtronic has announced that the FDA has approved the company’s self-expanding transcatheter aortic valve implantation (TAVI) system CoreValve Evolut for the management of intermediate-risk...

Essential Frailty Toolset may be best assessment of frailty for aortic...

Jonathan Afilalo (Division of Cardiology, Jewish General Hospital, McGill University, Montreal, Canada) and others report in the Journal of American College of Cardiology that...

FDA approve “first-in-class” resilient surgical valve

Edwards Lifesciences has FDA approval for its Inspiris Resilia surgical aortic valve, which a press release reports is the first in a new class...

NHS hospital failed to comply with UK law when it gave...

The UK’s Information Commissioner’s Office (ICO) has found that the Royal Free NHS Foundation Trust (London, UK) did not adhere to the UK’s Data...

CSI 2017: Global postmarket surveillance study to explore use of LAmbre...

LifeTech, at the 2017 Congenital and Structural Intervention Congress (CSI; 28 June—1 July, Frankfurt, Germany), announced the launch of a three-year global postmarket surveillance...

Further data to support use of new-generation drug-eluting stents in women

A new study from the Women in Innovation Initiative and Drug-Eluting Stents (WIN-DES) collaborative has found that the use of new-generation drug-eluting stents is...

Nearly one in 10 US TAVI procedures is off label but...

Ravi S Hira (Section of Cardiology, University of Washington, Seattle, USA) and others report in JAMA Cardiology that 9.5% of US transcatheter aortic valve...

Simple but effective animation shows difference between a MI and a...

The British Heart Foundation has produced a video to help the general public understand the difference between a myocardial infarction and a cardiac arrest. The...

New hybrid operating room at Getinge Experience Center in Germany

Getinge has announced the opening of a new modern hybrid operating room (OR) at its Experience Center in Rastatt, Germany. The Hybrid OR, a...

Haemodynamic support with Impella 2.5 heart pump significantly improves survival when...

  A study published in the Journal of Interventional Cardiology indicates that the use of the Impella 2.5 heart pump (Abiomed) is associated with a...

First European patient enrolled in study of percutaneous tricuspid repair system

Mitralign has announced the start of its SCOUT II study in Europe; the study is evaluating the company’s Trialign percutaneous system for the treatment...

Philips to acquire Spectranetics “to accelerate expansion” in its image-guided therapy...

Philips and Spectranetics have announced that they have entered into a definitive merger agreement. Pursuant to the agreement, a press release reports, Philips will...

EuroPCR 2017: Study provides “first step” towards showing long-term durability of...

New data presented, by Luca Testa (Department of Cardiology, IRCCS Policlinico S. Donato, Milan, Italy), at EuroPCR (16–19 May, Paris, France) indicates that there...

Patients benefit from participating in clinical trials

With our population rapidly ageing and improvements in care in other conditions—enabling people to live longer—cardiovascular disease remains the leading cause of death worldwide....

EuroPCR 2017: No risk factor identified for early stroke events in...

  A review of the neurological complications that occurred after surgical aortic valve replacement or transcatheter aortic valve implantation (TAVI) in the SURTAVI (Surgical replacement and...

Study confirms that volume matters for achieving lower in-hospital mortality after...

A study, published in EuroIntervention, provides further evidence that there is an inverse relationship between the number of transcatheter aortic valve implantation (TAVI) procedures...

EuroPCR 2017: Switching to clopidogrel after one month reduces bleeding without...

Data from the TOPIC (Timing of platelet inhibition after acute coronary syndrome) study indicate that swapping a new potent P2Y212 blocker for the less...

Bicuspid aortic stenosis: TAVI’s next challenge

Most of the initial registries, and the large randomised trials, for transcatheter aortic valve implantation (TAVI) excluded patients with bicuspid aortic valves. The presence...

Improving processes and outcome performance measures may be more be relevant...

Alexander C Fanaroff (Division of Cardiology, Duke University, Durham, USA) and others report in the Journal of the American College of Cardiology that nearly...

EuroPCR 2017: Greater risks with standard approach of dual antiplatelet therapy...

The ARTE study, which was simultaneously presented at EuroPCR (16–19 May, Paris, France) and published in JACC: Cardiovascular Interventions, indicates that dual antiplatelet therapy...

TVT 2017: Presentation showcases safety of Tempo temporary pacing lead

BioTrace Medical announced that its Tempo temporary pacing lead was featured in an oral presentation during the 2017 Transcatheter Valve Therapies (TVT) meeting (14–17...

Non-invasive approach could be used to improve valve opening functioning of...

Emmanuel Messas (Hôpital Européen Georges Pompidou, Paris, France) and colleagues report in JACC: Basic to Translational Science that pulsed cavitation ultrasound can be used...

Venus Medtech buys InterValve

Venus Medtech has purchased InterValve, which sells balloon aortic valvuloplasty products and is focused on transcatheter aortic valve treatment. A press release reports that...

US centres of TAVI excellence start to use newly approved Sentinel...

Claret Medical has announced that several of the largest centres of excellence for transcatheter aortic valve implantation (TAVI) have now performed the first US...

ESC calls for sex-specific drug dosages of cardiovascular medication

Sex-specific cardiovascular drug dosages are needed to reduce adverse reactions in women, according to a position paper from the European Society of Cardiology (ESC)....

Risk of bleeding with aspirin in patients older than 75 is...

Peter Rothwell (University of Oxford, Oxford, UK) and colleagues report in The Lancet that long-term use of aspirin in people aged 75 or older...

EuroPCR 2017: Safety of deferring stenting in acute coronary syndrome patients...

A pooled patient-level analysis of patients undergoing physiological assessment, with either fractional flow reserve (FFR) or instantaneous wave-free ratio (iFR), indicates that deferring coronary...

EuroPCR 2017: PCI outperforms medical management for treatment of chronic total...

According to a study presented at EuroPCR (16–19 May, Paris, France), compared with optimal medical therapy alone, percutaneous coronary intervention (PCI) significantly improves the...

Survival benefit of early intervention in non-STEMI patients is independent of...

Sameer Arora (Division of Cardiology, University of North Carolina at Chapel Hill, Chapel Hill, USA) and others report in Catheterizations and Cardiovascular Interventions that...

Dose-tracking system reduces radiation exposure to patients during PCI

A new study suggests that a novel skin dose-tracking system (Toshiba) may reduce radiation exposure in patients undergoing percutaneous coronary intervention (PCI). However, the...

HLT’s TAVI system implanted in first US patients

The first patients in an early feasibility study of HLT’s transcatheter aortic valve implantation (TAVI) system have been implanted with the device. The implant...

OrbusNeich announces FDA clearance and launch of coronary dilatation catheters

OrbusNeich has announced the launch of its Sapphire percutaneous coronary angiography balloon dilatation catheters (Sapphire II PRO and Sapphire NC Plus) following their recent...

Ruby anniversary: Peculiarities about the world’s first PCI

On 16 September 1977, Bernhard Meier helped Andreas Grüntzig to perform the world’s first in-human coronary angioplasty procedure. In this commentary, he reviews the...

TVT 2017: “I predict a very exciting and bright future” for...

This year marks the 10th anniversary of the Transcatheter Valve Therapies (TVT) meeting (14–17 June, Chicago, USA). Course director Martin B Leon (Interventional Vascular...

Sentinel becomes first cerebral protection device to receive FDA approval

Claret Medical has received regulatory clearance from the FDA for its Sentinel cerebral protection system, via de novo classification, meaning that the device can...

EuroPCR 2017: Interventional management of acute heart failure—which device, when and...

In this PCR video, filmed during EuroPCR (16–19 May, Paris, France), Atul Pathak (Clinique Pasteur, Toulouse, France) speaks to Daniel Burkhoff (Division of Cardiology, Columbia...

Award-wining system could be used to inform future surgeons about procedural...

David Wald (Barts Heart Centre, St Bartholomew’s Hospital, London, UK) and his 16-year-old son Ben have designed a system that will enable surgeons, via...

EuroPCR 2017: Study finds no association between implantation technique and risk...

A study—AIDA (Amsterdam investigator-initiated Absorb strategy all-comers trial)—presented at EuroPCR  (16–19 May, Paris, France) and published in The New England Journal of Medicine has...

Vinayak Bapat

Vinayak—“Vinnie”—Bapat (New York Presbyterian Hospital/Columbia Medical Center, New York, USA) was all set to become a fighter pilot in the Indian air force until...

Cardiovascular News Issue 45 – May 2017 US edition

The top story this issue (45; May 2017) reviews whether iFR, following the results of DEFINE-FLAIR and SWEDEHEART, is set to become the new...

Cardiovascular News Issue 45 – May 2017

The top story this issue (45; May 2017) reviews whether iFR, following the results of DEFINE-FLAIR and SWEDEHEART, is set to become the new...

EuroPCR 2017: Head-to-head study validates consistent performance of FFR microcatheter

ACIST Medical Systems announced results from the ACIST-FFR study (Assessment of catheter-based interrogation and standard techniques for fractional flow reserve measurement), which demonstrated—a press...

EuroPCR 2017: No stent thrombosis with Resolute Onyx drug-eluting stent 2mm

Data for  the Resolute Onyx drug-eluting 2mm stent (Medtronic), which were presented at EuroPCR (16–19 May, Paris, France), indicate that device is not associated...

EuroPCR 2017: Excellent early outcomes for Edwards Lifesciences’ self-expanding valve

According to late-breaking trial presented at EuroPCR (16–19 May, Paris, France), a novel self-expanding transcatheter aortic valve implantation device (TAVI, Centera, Edward Lifesciences) is...

EuroPCR 2017: Low risk of scaffold thrombosis with Magmaris

Data presented at EuroPCR (16–19 May, Paris, France) indicate that a metallic bioresorbable scaffold (Biotronik) is associated with a lower risk of scaffold thrombosis...

Positive results for Gore’s PFO closure device

Gore has announced positive results from the REDUCE study, which is assessing the safety and efficacy of its septal occluder devices for the percutaneous...

EuroPCR 2017: Lotus TAVI device has superior efficacy to CoreValve at...

Data from the REPRISE III trial indicate that the Lotus transcatheter aortic valve implantation (TAVI) device (Boston Scientific) is associated with a significantly lower...

EuroPCR 2017: Teleflex introduce new Arrow AC3 Optimus intra-aortic balloon pump

Teleflex showcased its complex percutaneous coronary intervention (PCI) product portfolio, recently acquired from the purchase of Vascular Solutions, and the new Arrow AC3 Optimus...

No difference in rate of adverse cardiovascular events when comparing anticoagulants

In patients undergoing transradial primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI), according to a study published in JACC: Cardiovascular Interventions,...

EuroPCR 2017: ABSORB China and ABSORB show both comparable safety and...

Data presented from ABSORB China and ABSORB Japan at EuroPCR (16–19 May, Paris, France) show the bioresorbable scaffold Absorb (Abbott Vascular) to have comparable...

SCAI 2017: New data from PLATINUM Diversity study provide further insight...

New analyses from the PLATINUM Diversity study underscore the need for greater understanding of the clinical and nonclinical barriers that can adversely affect stent-related...

Boston Scientific closes Symetis acquisition

Boston Scientific Corporation has announced the close of its acquisition of Symetis SA, a privately-held Swiss structural heart company focused on transcatheter aortic valve...

NaviGate Cardiac Structures reports first heterotopic transcatheter Gate tricuspid valved stent...

NaviGate Cardiac Structures has announced that the Gate catheter-guided tricuspid atrioventricular valved stent was implanted through the jugular vein one week ago in a...

The need to determine the relevance of stent malapposition

Despite a constant evolution in stent/scaffold design, stent failure is still perceived as a clinical problem. The process of drug-eluting stent struts thinning that...

The role of nurses in ensuring a patient-focused TAVI service

Preadmission clinics for patients awaiting elective procedures or surgery are not a new concept. Over the years, several studies have highlighted the multiple benefits...

Reduced baseline left ventricular function may explain female survival benefit after...

A new study indicates that the apparent survival benefit after transcatheter aortic valve implantation (TAVI) that women have over men relates to the baseline...

GE Healthcare receives FDA indication approval for Visipaque injection for use...

GE Healthcare announced that it has received an indication approval from the FDA for its imaging agent Visipaque (iodixanol) Injection. Visipaque 320mg Iodine/mL is...

LivaNova acquires Caisson Interventional

LivaNova has announced it has acquired the remaining outstanding interests in Caisson Interventional in support of its strategic growth initiatives. Based in Maple Grove...

Risk-adjusted 30-day readmission rates are not associated with in-hospital quality of...

Ambarish Pandey (Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, USA) and others report in JAMA Cardiology that risk-adjusted 30-day readmission rates...

Daiichi Sankyo initiates ENVISAGE-TAVI AF study to investigate once-daily edoxaban in...

The ENVISAGE-TAVI AF is the first study to evaluate the effects of a novel oral anticoagulant on clinical outcomes exclusively in atrial fibrillation patients...

Teleflex receives FDA 510(k) Clearance for its Arrow AC3 Optimus intra-aortic...

Teleflex has announced 510(k) clearance from the FDA for its AC3 Optimus intra-aortic balloon pump (IABP). A press release reports that device helps a...

Patient enrolled in STEMI DTU feasibility study

Abiomed announced today the enrolment of the first patient in the FDA approved prospective feasibility study, STEMI Door to Unloading (DTU) with Impella CP...

Multicentre study demonstrates 3D Echo image analysis with Philips’ HeartModelA.I. is...

Philips has announced the results from a global study indicating that automated three-dimensional echocardiographic (3DE) analysis of left-heart chambers is an accurate alternative to...

New data reaffirms value of Perceval for aortic valve replacement in...

LivaNova has announced the presentation of data from multiple studies demonstrating the safety and the effectiveness of the Perceval sutureless valve for aortic valve...

Meta-analysis supports transaortic approach in TAVI

A meta-analysis of single-centre studies indicates that the use of the transaortic appraoch in patients undergoing transcatheter aortic valve implantation (TAVI) is associated with...

High HbA1c levels after coronary intervention may predict risk of adverse...

A new study indicates that patients with glycosylated haemoglobin A (HbA1c) ≥7 at two years after undergoing percutaneous coronary intervention (PCI) have a higher...

Absorb GTS to be restricted to registry use only in Europe

Abbott Vascular has written a letter to European physicians to say that from 31 May, its bioresorbable vascular scaffold (Absorb) will only be available...

TAVI pacemaker issue is “an engineering problem that will be solved”

The SURTAVI trial indicates that transcatheter aortic valve implantation (TAVI)  with CoreValve/CoreValve Evolut R (Medtronic) is non-inferior to surgery for the management of severe...

Fantom II trial to include more complex cases

REVA Medical has announced that it has been granted approval to conduct an expanded clinical trial for its Fantom bioresorbable scaffold in Germany. The...

ACC 2017: Dual anti-thrombotic approach has similar risk of bleeding to...

The GEMINI-ACS study, which was simultaneously presented at the 2017 scientific sessions of the American College of Cardiology (ACC; 17–19 March, Washington, DC, USA)...

ACC 2017: Viagra may reduce cardiovascular outcomes after a first myocardial...

Daniel P Andersson (Department of Medicine, Karolinska Institutet, Unit of Endocrinology, Metabolism, and Diabetes, Karolinska University Hospital, Stockholm, Sweden) and others report in Heart...

The use of bioresorbable scaffold in clinical practice

At JIM 2017 (9-11 February, Milan, Italy), we spoke to Bernardo Cortese (Interventional Cardiology, A.O. Fatebenefratelli, Milano, Italy) about how he uses bioresorbable scaffolds...

Atherectomy is an important tool for optimising results of PCI in...

Evan Shlofmitz (Northwell Health, Manhasset, USA) presented the results of the COAP-PCI (Clinical outcomes of atherectomy prior to percutaneous coronary intervention) study at Cardiovascular...

ACC 2017: FDA approves launch of CoreValve Evolut Pro

The FDA has approved Medtronic’s CoreValve Evolut Pro transcatheter aortic valve implantation (TAVI) device. This approval follows data for the device that were presented...

ACC 2017: “iFR may be the new standard” of physiological assessment...

Writing in The New England Journal of Medicine, Deepak L Bhatt (Brigham and Women’s Hospital and Vascular Center and Harvard Medical School, Boston, USA)...

ACC 2017: PCSK9 inhibitor evolocumab significantly reduces the risk of cardiovascular...

Data for a new drug that inhibits proprotein convertase subtilisin-kexin type 9 (PCSK9) show that it is associated with a near 60% reduction in...

ACC 2017: Two-year rate of target lesion failure significantly higher with...

Two-year data from the ABSORB III study indicate that a bioresorbable vascular scaffold (Absorb, Abbott Vascular) is associated with a significantly higher rate of...

ACC 2017: No significant differences in two-year morality between bicuspid and...

Sung-Han Yoon (Cedars-Sinai Heart Institute, Los Angeles, USA) and others report in the Journal of the American College of Cardiology that all-cause mortality at...

ACC 2017: CoreValve non-inferior to surgery in intermediate-risk patients

Results from the SURTAVI clinical trial, which were presented today at the 2017 scientific sessions of the American College of Cardiology (17–19 March, Washington,...

“Excellent early patency rates” for VEST device

Vascular Graft Solutions has announced interim results of VEST III, a post-market randomised controlled study, to demonstrate the clinical significance of the venous external...

New “smART” kit for radial access launched

​Centurion Medical Products has launched its “smART” kit for radial arterial catheterisation onto the market. According to a press release, the kit positively impacts...

Innovative Cardiovascular Solutions announces successful first use of its Emblok embolic...

  Innovative Cardiovascular Solutions has announced the successful first European clinical cases using its Emblok embolic protection system in patients undergoing transcatheter aortic valve implantation...

Five-fold increase in mortality in acute cardiac patients with delirium

A study published in European Heart Journal: Acute Cardiovascular Care indicates that delirium is associated with a five-fold increase in mortality in acute cardiac...

Early hospital discharge after TAVI less likely in women

A study, published in the Journal of Interventional Cardiology, indicates that females, bleeding, and blood transfusions—among others—are associated with lower odds for an early...

“Simple five-item risk score” could be used to predict bleeding risk...

Francesco Costa (Swiss Cardiovascular Center Bern, Bern University Hospital, Bern, Switzerland) and others report in The Lancet that the PRECISE-DAPT score—“a simple five-item risk...

Brian Brogie names as new vice president of manufacturing and facilities...

SynCardia, manufacturer of the world’s first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, has announced that Brian Brogie has...

Melody pulmonary heart valve receives FDA approval for valve-in-valve use

Following FDA approval, Medtronic’s Melody transcatheter pulmonary heart valve can now be used to treat patients whose surgical bioprosthetic pulmonary heart valves have failed....

New research indicates “harmless” painkillers are associated with an increased risk...

According to a study published in European Heart Journal–Cardiovascular Pharmacotherapy, painkillers that are traditionally considered harmless by the general public are associated with increased...

Study indicates that Impella heart pump reduces acute kidney injury during...

A new study published in Circulation Research finds that the use of haemodynamic support with Impella 2.5 heart pump during high-risk percutaneous coronary intervention...

American College of Cardiology update appropriate use criteria for performing coronary...

The American College of Cardiology (ACC), along with several partnering organisations, has released updated appropriate use criteria for performing coronary revascularisation in patients with...

ADVERT: SYNERGY™

Everolimus-Eluting Platinum Chromium Coronary Stent System Drug Eluting stent technology with durable polymer has shown encouraging efficacy compared to bare metal stents, significantly reducing restenosis...

RenalGuard significantly reduces risk of contrast-induced acute kidney injury in high-risk...

A new meta-analysis, published in JACC: Cardiovascular Interventions, indicates that RenalGuard (RenalGuard Solutions) significantly reduces the risk of contrast-induced acute kidney injury in high-risk...

Cobra PzF stent approved for commercial use in the USA

The FDA has approved a nano-coated coronary stent system—CeloNova Biosciences’ Cobra PzF—for use in percutaneous coronary intervention (PCI), specifically to improve coronary luminal diameter....

Valve replacement may better than vavluloplasty for aortic stenosis patients with...

A new study published in Catheterization and Cardiovascular Interventions indicates that valve replacement, via surgery or transcatheter aortic valve implantation (TAVI), significantly increases survival...

Contemporary Issues in Complete Revascularisation

  This educational supplement is only for readers in countries outside Europe.  In this educational supplement, sponsored by Boston Scientific, Cardiovascular News explores both complete and...

“No-touch” CABG reduces postoperative stroke and short-term mortality

A network meta-analysis, published in the Journal of the American College of Cardiology, indicates that an off-pump coronary artery bypass grafting (CABG) technique that...

BTG’s EKOS control unit 4.0 receives FDA 510(K) clearance

FDA 510(k) clearance has been granted to BTG’s EKOS control unit 4.0. A press release reports that the system includes an ultrasonic device that...

FDA advisory panel recommend de novo approval of Sentinel cerebral protection...

In an open public hearing of the FDA’s circulatory system devices panel, according to a press release, nearly all panel members recommended the de...

Philips launch next-generation, image-guided therapy platform to enhance patient care and...

Philips has announced the global launch of Azurion—its next-generation image-guided therapy platform that integrates advanced interventional tools into one clinician platform. Combining advancements in...

Transradial PCI reduces costs

A new study published in JACC: Cardiovascular Interventions indicates that the transradial percutaneous coronary intervention (PCI) is associated with an average cost of US$13,389...

Locking mechanism problems prompt Boston Scientific to recall all ranges of...

According to Reuters, Boston Scientific is recalling all ranges of its transcatheter aortic valve implantation (TAVI) device Lotus. The news agency reports that the...

PCI does not confer mortality benefit for diabetic patients with chronic...

Ki Hong Choi (Division of Cardiology, Department of Medicine, Cardiac and Vascular Centre, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea)...

First patient enrolled in the US LEADERS FREE II trial of...

Biosensors has announced that the first patient has been enrolled in LEADERS FREE II—the BioFreedom pivotal study, which is being conducted under an investigational...

FDA approves Biotronik’s Pro-Kinetic Energy bare metal stent

Biotronik’s Pro-Kinetic Energy bare metal stent has received FDA approval, which is based on the results of the BIOHELIX-I clinical study. Therefore, the stent, which...

Physicians may be overlooking patients’ desire to avoid dual antiplatelet therapy...

A study, published in Catheterization and Cardiovascular Interventions, found that most patients undergoing coronary angiography believe that—following percutaneous coronary intervention (PCI)—avoiding dual antiplatelet therapy...

Cardiovascular News Issue 44 – February 2017 US edition

In Issue 44 (February 2017), we review why EXCEL and NOBLE had such different findings for left main PCI, the three-year outcomes of the ABSORB...

Cardiovascular News Issue 44 – February 2017

In Issue 44 (February 2017), we review why EXCEL and NOBLE had such different findings for left main PCI, the three-year outcomes of the ABSORB...

Rebecca Hahn

Rebecca Hahn (Center for Interventional Vascular Therapy, Columbia University Medical Center, New York, USA) has been at the forefront of the developing field of interventional...

The implications of ABSORB II three-year results for the future of...

The idea of a fully bioresorbable scaffold is attractive as the need for mechanical support for the healing artery after percutaneous coronary intervention (PCI)...

Procedural complexity should be considered when deciding duration of dual antiplatelet...

Gennaro Giustino and others report in the Journal of American College of Cardiology that—alongside other established risk factors—procedural complexity “is an important parameter to...

Understanding and managing functional tricuspid regurgitation

Functional tricuspid regurgitation is increasingly recognised as an important clinical condition for which surgical repair is being applied.1 It primarily arises from left heart...

“Telestenting” is possible with robotic PCI

Ryan D Madder (Frederik Meijer Heart & Vascular Institute, Spectrum Health, Grand Rapids, USA) and others report in EuroIntervention that “telestenting”—ie. when the operator...

Meta-analysis indicates embolic protection does reduce stroke after TAVI

In a research letter published in the Journal of the American College of Cardiology, Gennaro Giustino (The Icahn School of Medicine, Mount Sinai Hospital,...

Performing PCI in comatose survivors of cardiac arrest

Because of a significant improvement in the prehospital treatment of patients with out-of-hospital cardiac arrest, an increasing number of resuscitated, comatose patients are being...

Transcatheter Mitral “valve-in-valve” replacement: The patient’s perspective

In this video, by Heart Valve Surgery, Paul Powers describes his life before and after undergoing transcatheter mitral "valve-in-valve" implantation. The procedure, he explains, was...

Terumo completes acquisition of vascular closure business and other assets of...

Terumo has announced that it has completed its acquisition of certain assets owned by Abbott and St Jude Medical. Terumo has acquired the Angio-Seal and...

Left atrial appendage thrombus may increase the risk of stroke after...

Sonny Palmer (St Vincent’s Hospital, Melbourne, Australia) and others report in JACC: Cardiovascular Interventions that left atrial appendage thrombus, as identified with computed tomography...

Homemade pelvic drape significantly reduces radiation exposure to the operator during...

The RADIATION (Radiation dose in percutaneous coronary procedures through transradial approach using dedicated radiation shields) study, published in EuroIntervention, indicates that using a lower...

TAVI company Direct Flow Medical closes after failing to secure funding

Direct Flow Medical, which markets a CE-marked transcatheter aortic valve implantation (TAVI) device, has closed after funding from a Chinese pharmaceutical company did not...

Combining MitraClip mitral valve repair with left atrial appendage occlusion is...

Shingo Kuwata (University Heart Center, Zurich, Switzerland) and others report in Eurointervention that atrial fibrillation is a “frequent comorbidity” in patients with mitral regurgitation...

JACC: Cardiovascular Imaging also to get a new editor-in-chief

Following the recent announcement from the American College of Cardiology (ACC) that David J Moliterno is to become the new editor-in-chief of JACC: Cardiovascular...

Boston Scientific may have resolved issue with Lotus Edge device

According a news report on Mass Device, Boston Scientific has “found a fix” for the problem with its next-generation transcatheter aortic valve implantation (TAVI)...

Enrolment completed for ACIST-FFR multicentre study

ACIST Medical Systems has announced that enrolment has been completed in its ACIST-FFR study—Assessment of catheter-based interrogation and standard techniques for fractional flow reserve...

David J Moliterno to become editor-in-chief of JACC: Cardiovascular Interventions

The American College of Cardiology (ACC) has named David J Moliterno (Jack M Gill Chair, Department of Internal Medicine, University of Kentucky, Lexington, USA)...

The management of leaflet thickening after TAVI remains controversial

Ryo Yanagisawa (Department of Cardiology, Keio University School of Medicine, Tokyo, Japan) and colleagues report in JACC: Cardiovascular Imaging that hypoattenuated leaflet thickening after...

Few cardiologists take steps to avoid radiation exposure during pregnancy despite...

The Women in Cardiology (WIC) section of the American College of Cardiology (ACC) report that 47% of female cardiologists have avoided being pregnant during...

CardiAMP heart failure trial initiated at two US centres

BioCardia has announced the initiation of its CardiAMP heart failure pivotal trial—a randomised, controlled, multicentre study of up to 260 patients evaluating CardiAMP cell...

MicroPort completes patient enrolment of VitaFlow pre-market clinical trial

MicroPort Medical has recently completed the patient enrolment of the pre-market clinical trial of its self-developed VitaFlow transcatheter aortic valve and delivery system (VitaFlow),...

First patient enrolled in Somahulation’s CABG European registry of DuraGraft

Somahlution has announced enrolment of the first patient in its DuraGraft coronary artery bypass grafting (CABG) European Registry. The registry will evaluate DuraGraft—a vascular...

Abbott completes acquisition of St Jude Medical

Abbott Vascular has completed its acquisition of St Jude Medical. This follows receipt of all regulatory clearances necessary for closing. A company press release states that the transaction establishes...

Transcatheter valve-in-ring implantation is feasible for reducing tricuspid regurgitation

A new study indicates that “transcatheter valve-in ring”—implanting a transcatheter valve in a surgically placed annuloplasty ring—may be a clinically effective approach for managing...

Perform PCI prior to TAVI in patients with both coronary artery...

Stephen Ramee (Ochsner Medical Center, New Orleans, USA) and others outline in a paper in JACC: Cardiovascular Interventions, the rationale for performing percutaneous coronary...

Patient with tricuspid regurgitation successfully treated with world’s first transcatheter tricuspid...

NaviGate Cardiac Structures has announced that a novel valved stent that can capture the enlarged annulus in patients with functional tricuspid regurgitation was successfully...

Santa is not checking his list about whether you’re naughty or...

A new study, published in The BMJ, indicates that for centuries, children have been lied to about Santa/St Nick/Father Christmas—he does not actually care...

Infection in the setting of STEMI

The association between infections and acute coronary syndromes has been the subject of interest for many years. Recent evidence demonstrates an increased risk of...

Revised European guidelines on cardiovascular disease prevention: What you need to...

The new European guidelines on cardiovascular disease prevention in clinical practice1 are an update of the version published in 2012.2 They represent an evidence-based...

Minimally invasive TAVI has “several potential benefits”

Recently, there has been a move towards transcatheter aortic valve implantation (TAVI) procedures that are more “minimally invasive”. In this interview, Jay Giri (Cardiovascular...

FDA pre-market approval for the Impella heart pump for high-risk PCI...

Abiomed has expanded its FDA pre-market approval for Impella heart pump use in high-risk percutaneous coronary interventions (PCI) to include its Impella CP heart...

Teleflex to acquire Vascular Solutions in US$1 billion deal

Teleflex is to acquire Vascular Solutions in a transaction valued at approximately US$1 billion. Under the terms of the agreement, Teleflex will acquire all...

Novel locking microcatheter could improve procedural success rates of chronic total...

  Simon Wilson (Royal Infirmary of Edinburgh, Edinburgh, UK) and others report in EuroIntervention that the use of a novel microcatheter with a guidewire locking...

CADILLAC risk score could be used to identify STEMI patients for...

Musa A Sharkawi (Department of Cardiovascular Medicine, Hartford Hospital, Hartford, USA) and others report in Catheterization and Cardiovascular Interventions that the CADILLAC risk score...

FDA grant Cardiac Dimensions investigational device exemption approval to conduct study

Cardiac Dimensions has received FDA approval for its investigational device exemption (IDE) CARILLON trial. The multicentre, blinded, randomised controlled trial is designed to evaluate...

Ran Kornowski

Ran Kornowski (Department of Cardiology, Cardiac Catheterization Laboratories, Rabin Medical Center, Tel Aviv University, Tel Aviv, Israel) talks to Cardiovascular News about his career...

Focusing on risk-adjusted mortality in public reporting produces misleading figures

In Catheterization and Cardiovascular Interventions, Lloyd Klein (Rush Medical College, Chicago, USA) and others outline the 2016 revised Society for Cardiac Angiography and Interventions...

Edward Lifesciences to acquire Valtech

Valtech Cardio has agreed to be acquired by Edwards Lifesciences. The acquisition will give Edwards access to Valtech’s Cardioband reconstruction system (Cardioband) for transcatheter...

Neovasc receives approval to launch European study of Tiara transcatheter mitral...

Neovasc has received both regulatory and ethics committee approval to initiate the Tiara transcatheter mitral valve replacement study (TIARA II) in Italy. The study...

RSNA 2016: Siemens Healthineers debuts innovative, robot-supported ARTIS pheno angiography system

At the 2016 meeting of the Radiological Society of North America (RSNA; 27 November–2 December, Chicago, USA), Siemens Healthineers has unveiled the robot-supported ARTIS pheno...

RSNA 2016: Toshiba Medical aims to transforms CT Imaging with the...

With the introduction of the AquilionTM ONE/GENESIS Edition, the new system from Toshiba Medical that builds upon a 10-year history of leadership in area...

OrbusNeich launch next generation of its Combo dual therapy stent

OrbusNeich launched its latest generation dual therapy stent, the Combo Plus. According to a press release, the Combo Plus has a unique anti-CD34 antibody...

CardioCel now approved for use in the UAE

Admedus has announced that, in collaboration with its regional partner Genpharm, it has received market approval for CardioCel in the United Arab Emirates (UAE)...

First Revivent transcatheter ventricular enhancement procedure for ischaemic cardiomyopathy performed in...

BioVentrix has announced the first clinical use in the Netherlands of its closed-chest Revivent transcatheter (TC) ventricular enhancement system. The less invasive ventricular enhancement...

AHA 2016: Mount Sinai cardiologists honoured

Valentin Fuster (director of Mount Sinai Heart and physician-in-chief of The Mount Sinai Hospital, New York, USA) and Jeffrey W Olin (professor of Cardiology and Director...

ADVERTORIAL: Enhanced deliverability means Trifecta™ valve is now easier to implant

The new St. Jude Medical™ Trifecta™ valve with Glide™ Technology (GT) features several enhancements that make the device easier to implant in patients with...

ADVERTORIAL: Know where you are with SyncVision technology

SyncVision (Philips Volcano) enables co-registration between angiogram and intravascular ultrasound (IVUS) images during percutaneous coronary intervention (PCI). Following recent CE mark and FDA clearance...

AHA 2016: Mortality rate with FFR-guided treatment of multivessel disease is...

The results of the FUTURE (Functional testing underlying revascularisation) trial indicate that the use of fractional flow reserve (FFR) to guide treatment—medical management, percutaneous...

AHA 2016: Heparin plus tirofiban is safe and effective for use...

A new study, by researchers from the Intermountain Medical Center Heart Institute (Salt Lake City, USA), indicates that there are no significant differences in...

HeartFlow FFRct approved for use in Japan

HeartFlow has announced the approval of its HeartFlow FFRCT analysis by the Japanese Ministry of Health, Labour and Welfare. A press release reports that...

AHA 2016: Low-dose rivaroxaban reduces clinically significant bleeding in PCI patients...

Two drug regimens involving low doses of rivaroxaban (Xarelto, Bayer)—one with a 15mg once daily dose of the drug and a P2Y12 inhibitor and...

AHA 2016: MOMENTUM 3 shows HeartMate 3 LVAD improves clinical outcomes...

The results of the MOMENTUM 3 US IDE clinical study, which were presented at a late-breaking clinical trial at the 2016 American Heart Association...

AHA 2016: Strong positive one-year data for Corvia Medical’s InterAtrial shunt...

Corvia Medical has announced one-year follow-up data from the REDUCE LAP-HF clinical study of its InterAtrial shunt device. The device is the world's first...

AHA 2016: Incomplete revascularisation after PCI increases risk of adverse events...

Ehrin J Armstrong (Section of Cardiology, Denver VA Medical Center and University of Colorado School of Medicine, Aurora, USA) and others report in JACC:...

AHA 2016: The Medicines Company and Alnylam Pharmaceuticals present positive results...

The Medicines Company and Alnylam Pharmaceuticals have announced positive results from the analysis of day 90 data for 497 patients, as well as analysis...

Trialign system successfully used to treat patient with tricuspid regurgitation because...

Mitralign has announced the successful compassionate use treatment of a patient suffering from tricuspid regurgitation due to a cardiac implantable electronic device lead, with...

AHA 2016: Two thirds of patients experience plaque regression with the...

Amgen has announced that adding its PCSK9 inhibitor evolocumab (Repatha) to optimised statin therapy results in statistically significant regression of atherosclerosis in patients with...

Cardiovascular Research Foundation to launch structural heart disease journal

The Cardiovascular Research Foundation (CRF) is to launch a new international journal focusing on the diagnosis and treatment of structural heart disease and the...

Patient enrolment complete in study assessing use of dabigatran atrial fibrillation...

  Patient enrolment into the international Phase IIIb RE-DUAL PCI study is complete. The study is evaluating the safety and efficacy of dabigatran (Pradaxa, Boehringer...

Terumo to distribute STARSystem for radial access procedures in Europe

Terumo Europe has entered into a distribution agreement with New Zealand company Adept Medical to make the STARSystem available to clinicians working across Western...

Cardiovascular News Issue 43 – November 2016 US Edition

Highlights: Lower revascularisation rate means drug-eluting stents are still preferred despite no long-term survival benefit; Optical coherence tomography significantly improves functional outcomes after PCI;...

Cardiovascular News Issue 43 – November 2016

Highlights: Lower revascularisation rate means drug-eluting stents are still preferred despite no long-term survival benefit; Optical coherence tomography significantly improves functional outcomes after PCI;...

TCT 2016: Three-year data fail to show Absorb to be superior...

According to the three-year results of the ABSORB II trial, a bioresorbable vascular scaffold (Absorb, Abbott Vascular) does not provide superior vasomotor reactivity than...

TCT 2016: Different endpoints may have led to different outcomes for...

Two randomised controlled trials have produced what appears to be conflicting results for how left main percutaneous coronary intervention (PCI) compares with coronary artery...

TCT 2016: Patent foramen ovale closure is more effective than medical...

Final results from the RESPECT trial found that percutaneously closing a patent foramen ovale (PFO) using the Amplatzer PFO Occluder (St Jude Medical) was...

Pacemaker after TAVI is associated with worse outcomes

A study in JACC: Cardiovascular Interventions indicates that patients who require a pacemaker after undergoing transcatheter aortic valve implantation (TAVI) often have worse outcomes...

Pfizer discontinues the global development of its investigational PCSK9 inhibitor

Pfizer is to discontinue the global clinical development program for bococizumab—its investigational PCSK9 inhibitor. According to a press release, the totality of clinical information...

510(K) clearance for Merit Medical’s SwiftNinja steerable microcatheter

Merit Medical has received 510(k) clearance for its SwiftNinja steerable microcatheter. The clearance covers peripheral and coronary applications. With the exception of Japan, Merit...

Fresenius Medical Care acquires Xenios AG

Xenios AG has become part of Fresenius Medical Care. A press release reports that Xenios is driving innovation in minimally invasive lung and heart...

Svelte Medical launches DIRECT III post-market registry study

Svelte Medical Systems has announced the start of enrolment in the DIRECT III post-market registry study. DIRECT III is an “all-comer” study in Europe...

NICE recommends dual antiplatelet therapy with ticagrelor and aspirin

The National Institute of Health and Care Excellence (NICE) has published a final appraisal determination that states dual antiplatelet therapy with ticagrelor 60mg (Brilique,...

TCT 2016: Positive data for transcatheter tricuspid repair with Trialign

Mitralign presented 30-day data from the SCOUT I study, which designed to evaluate the performance of its Trialign system for tricuspid repair, at the...

TCT 2016: Transfemoral TAVI improves quality of life in intermediate-risk patients

Data presented at the 2016 Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 October–2 November, Washington, DC, USA) indicate that intermediate-risk patients who undergo transcatheter aortic...

TCT 2016: Tiara TMVI device highlighted in presentations

Neovasc has announced today its notable presentations at the 2016 Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 October–2 November, Washington, DC, USA). On 31 October,...

TCT 2016: CoreValve Evolut R continues to be associated with good...

Medtronic has unveiled new clinical data that shows that patients treated with its self-expanding CoreValve  Evolut R transcatheter aortic valve implantation (TAVI) device continued...

NICE should develop heart valve guidelines says Heart Valve Voice

UK charity Heart Valve Voice has launched a report—Towards a Heart Healthy Future: a 2020 Vision for Heart Valve Disease’—that sets out recommendations to...

TCT 2016: “Excellent” rates of late lumen loss with Desolve bioresorbable...

Six-month clinical data for Elixir Medical’s bioresorbable scaffold (Desolve) were presented at the 2016 Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 October–2 November, Washington, DC,...

TCT 2016: Cardiovascular System initiates largest ever randomised trial of coronary...

At the 2016 Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 October–2 November, Washington, DC, USA), Cardiovascular Systems debuted the design of its new ECLIPSE clinical...

Arterys receives 510(k) clearance for its cloud-based medical image visualization and...

Arterys has received 510(k) clearance from the FDA for its Arterys Software. This clearance allows the Arterys product to be used in clinical settings...

Charity believes NHS programme will leave hundreds of atrial fibrillation patients...

Arrhythmia Alliance, the UK-based heart rhythm charity, is calling on NHS England to reconsider a programme that it says will mean the “hundreds” of...

TCT 2016: High implant success rates with St Jude Medical’s Amulet...

A study presented at the last late-breaking trial session of the 2016 Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 October-2 November, Washington, DC, USA) indicates...

TCT 2016: Women and minorities have a significantly higher risk...

Data from the PLATINUM DIVERSITY trial, which was presented at the 2016 Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 October–2 November, Washington DC, USA), indicates...

TCT 2016: SENTINEL trial fails to meet overall primary efficacy endpoint...

The SENTINEL trial, which was presented at the 2016 Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 October-2 November, Washington , DC, USA) today, has not...

TCT 2016: Physicians discuss their positive experiences of using a metallic...

At a symposium at the 2016 Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 October-2 November, Washington, DC, USA), physicians discussed their first experiences with a...